C-terminal	B-protein
activating	I-protein
and	I-protein
inhibitory	I-protein
domains	I-protein
determine	O
the	O
transactivation	O
potential	O
of	O
BSAP	B-protein
(	O
Pax-5	B-DNA
)	O
,	O
Pax-2	B-DNA
and	O
Pax-8	B-DNA
.	O

Pax-5	B-DNA
encodes	O
the	O
transcription	B-protein
factor	I-protein
BSAP	B-protein
which	O
plays	O
an	O
essential	O
role	O
in	O
early	O
B	O
cell	O
development	O
and	O
midbrain	O
patterning	O
.	O

In	O
this	O
study	O
we	O
have	O
analysed	O
the	O
structural	O
requirements	O
for	O
transcriptional	O
activation	O
by	O
BSAP	B-protein
.	O

In	O
vitro	O
mutagenesis	O
and	O
transient	O
transfection	O
experiments	O
indicate	O
that	O
the	O
C-terminal	B-protein
serine/threonine/proline-rich	I-protein
region	I-protein
of	O
BSAP	B-protein
contains	O
a	O
potent	O
transactivation	B-protein
domain	I-protein
of	O
55	O
amino	O
acids	O
which	O
is	O
active	O
from	O
promoter	B-DNA
and	I-DNA
enhancer	I-DNA
positions	I-DNA
.	O

This	O
transactivation	B-protein
domain	I-protein
was	O
found	O
to	O
be	O
inactivated	O
by	O
a	O
naturally	O
occurring	O
frameshift	O
mutation	O
in	O
one	O
PAX-5	B-DNA
allele	I-DNA
of	O
the	O
acute	B-cell_line
lymphoblastic	I-cell_line
leukemia	I-cell_line
cell	I-cell_line
line	I-cell_line
REH	I-cell_line
.	O

The	O
function	O
of	O
the	O
transactivation	B-protein
domain	I-protein
is	O
negatively	O
regulated	O
by	O
adjacent	O
sequences	O
from	O
the	O
extreme	B-protein
C-terminus	I-protein
.	O

The	O
activating	O
and	O
inhibitory	O
domains	O
function	O
together	O
as	O
an	O
independent	O
regulatory	O
module	O
in	O
different	O
cell	O
types	O
as	O
shown	O
by	O
fusion	O
to	O
the	O
GAL4	B-protein
DNA	I-protein
binding	I-protein
domain	I-protein
.	O

The	O
same	O
arrangement	O
of	O
positively	B-DNA
and	I-DNA
negatively	I-DNA
acting	I-DNA
sequences	I-DNA
has	O
been	O
conserved	O
in	O
the	O
mammalian	B-DNA
Pax-2	I-DNA
and	O
Pax-8	B-DNA
,	O
the	O
zebrafish	B-DNA
Pax-b	I-DNA
as	O
well	O
as	O
the	O
sea	B-protein
urchin	I-protein
Pax-258	I-protein
proteins	I-protein
.	O

These	O
data	O
demonstrate	O
that	O
the	O
transcriptional	O
competence	O
of	O
a	O
subfamily	O
of	O
Pax	B-protein
proteins	I-protein
is	O
determined	O
by	O
a	O
C-terminal	B-protein
regulatory	I-protein
module	I-protein
composed	O
of	O
activating	B-DNA
and	I-DNA
inhibitory	I-DNA
sequences	I-DNA
.	O

The	NULL
EMBO	NULL
Journal	NULL
vol.15	NULL
no.8	NULL
pp.1971-1982	NULL
,	NULL
1996	NULL
C-terminal	NULL
activating	NULL
and	NULL
inhibitory	NULL
domains	NULL
determine	NULL
the	NULL
transactivation	NULL
potential	NULL
of	NULL
BSAP	NULL
(	NULL
Pax-5	NULL
)	NULL
,	NULL
Pax-2	NULL
and	NULL
Pax-8	NULL
Petra	NULL
Dorfler	NULL
and	NULL
Meinrad	NULL
Busslinger	NULL
'	NULL
Research	NULL
Institute	NULL
of	NULL
Molecular	NULL
Pathology	NULL
.	NULL

Dr	NULL
Bohr-Gasse	NULL
7	NULL
,	NULL
A-1030	NULL
Vienna	NULL
.	NULL

Austria	NULL
'Corresponding	NULL
author	NULL
Pax-5	NULL
encodes	NULL
the	NULL
transcription	NULL
factor	NULL
BSAP	NULL
which	NULL
plays	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
early	NULL
B	NULL
cell	NULL
development	NULL
and	NULL
midbrain	NULL
patterning	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
have	NULL
analysed	NULL
the	NULL
structural	NULL
requirements	NULL
for	NULL
transcriptional	NULL
activation	NULL
by	NULL
BSAP	NULL
.	NULL

In	NULL
vitro	NULL
mutagenesis	NULL
and	NULL
transient	NULL
transfection	NULL
experiments	NULL
indicate	NULL
that	NULL
the	NULL
C-terminal	NULL
serine/threonine/proline-rich	NULL
region	NULL
of	NULL
BSAP	NULL
contains	NULL
a	NULL
potent	NULL
transactivation	NULL
domain	NULL
of	NULL
55	NULL
amino	NULL
acids	NULL
which	NULL
is	NULL
active	NULL
from	NULL
promoter	NULL
and	NULL
enhancer	NULL
positions	NULL
.	NULL

This	NULL
transactivation	NULL
domain	NULL
was	NULL
found	NULL
to	NULL
be	NULL
inactiva-ted	NULL
by	NULL
a	NULL
naturally	NULL
occurring	NULL
frameshift	NULL
mutation	NULL
in	NULL
one	NULL
PAX-5	NULL
allele	NULL
of	NULL
the	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
cell	NULL
line	NULL
REH	NULL
.	NULL

The	NULL
function	NULL
of	NULL
the	NULL
transactivation	NULL
domain	NULL
is	NULL
negatively	NULL
regulated	NULL
by	NULL
adjacent	NULL
sequences	NULL
from	NULL
the	NULL
extreme	NULL
C-terminus	NULL
.	NULL

The	NULL
activating	NULL
and	NULL
inhibitory	NULL
domains	NULL
function	NULL
together	NULL
as	NULL
an	NULL
independent	NULL
regulatory	NULL
module	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
as	NULL
shown	NULL
by	NULL
fusion	NULL
to	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

The	NULL
same	NULL
arrangement	NULL
of	NULL
positively	NULL
and	NULL
negatively	NULL
acting	NULL
sequences	NULL
has	NULL
been	NULL
conserved	NULL
in	NULL
the	NULL
mammalian	NULL
Pax-2	NULL
and	NULL
Pax-8	NULL
,	NULL
the	NULL
zebrafish	NULL
Pax-b	NULL
as	NULL
well	NULL
as	NULL
the	NULL
sea	NULL
urchin	NULL
Pax-258	NULL
proteins	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
that	NULL
the	NULL
transcriptional	NULL
competence	NULL
of	NULL
a	NULL
subfamily	NULL
of	NULL
Pax	NULL
proteins	NULL
is	NULL
determined	NULL
by	NULL
a	NULL
C-terminal	NULL
regulatory	NULL
module	NULL
composed	NULL
of	NULL
activating	NULL
and	NULL
inhibitory	NULL
sequences	NULL
.	NULL

Keywords	NULL
:	NULL
BSAP	NULL
(	NULL
Pax-5	NULL
)	NULL
/negative	NULL
regulation/Pax-2/Pax-8/	NULL
transactivation	NULL
Introduction	NULL
The	NULL
paired	NULL
box	NULL
containing	NULL
(	NULL
Pax	NULL
)	NULL
genes	NULL
constitute	NULL
a	NULL
small	NULL
family	NULL
of	NULL
conserved	NULL
developmental	NULL
control	NULL
genes	NULL
which	NULL
can	NULL
be	NULL
grouped	NULL
into	NULL
different	NULL
subclasses	NULL
according	NULL
to	NULL
structural	NULL
similarities	NULL
(	NULL
reviewed	NULL
by	NULL
Noll	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
nine	NULL
mammalian	NULL
Pax	NULL
genes	NULL
are	NULL
known	NULL
to	NULL
encode	NULL
transcription	NULL
factors	NULL
with	NULL
important	NULL
functions	NULL
in	NULL
embryonic	NULL
pattern	NULL
formation	NULL
,	NULL
which	NULL
is	NULL
best	NULL
illustrated	NULL
by	NULL
their	NULL
association	NULL
with	NULL
mouse	NULL
developmental	NULL
mutants	NULL
and	NULL
human	NULL
disease	NULL
syndromes	NULL
(	NULL
reviewed	NULL
by	NULL
Stuart	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
demonstrated	NULL
that	NULL
the	NULL
B	NULL
cell-specific	NULL
transcription	NULL
factor	NULL
BSAP	NULL
is	NULL
encoded	NULL
by	NULL
the	NULL
Pax-5	NULL
gene	NULL
(	NULL
reviewed	NULL
by	NULL
Busslinger	NULL
and	NULL
Urbanek	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

BSAP	NULL
is	NULL
expressed	NULL
at	NULL
all	NULL
stages	NULL
of	NULL
B	NULL
cell	NULL
development	NULL
except	NULL
in	NULL
terminally	NULL
differentiated	NULL
plasma	NULL
cells	NULL
(	NULL
Barberis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
and	NULL
regulates	NULL
the	NULL
CD19	NULL
gene	NULL
which	NULL
codes	NULL
for	NULL
a	NULL
co-stimulatory	NULL
molecule	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
receptor	NULL
(	NULL
Kozmik	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

In	NULL
©	NULL
Oxford	NULL
University	NULL
Press	NULL
addition	NULL
to	NULL
all	NULL
B-lymphoid	NULL
tissues	NULL
,	NULL
the	NULL
Pax-5	NULL
gene	NULL
is	NULL
also	NULL
expressed	NULL
in	NULL
the	NULL
developing	NULL
midbrain	NULL
and	NULL
adult	NULL
testis	NULL
of	NULL
the	NULL
mouse	NULL
(	NULL
Adams	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

In	NULL
accordance	NULL
with	NULL
this	NULL
expression	NULL
pattern	NULL
,	NULL
gene	NULL
inactivation	NULL
in	NULL
the	NULL
mouse	NULL
germline	NULL
revealed	NULL
that	NULL
Pax-5	NULL
plays	NULL
a	NULL
important	NULL
role	NULL
in	NULL
B-lympho-poiesis	NULL
and	NULL
midbrain	NULL
development	NULL
(	NULL
Urbdnek	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
transcription	NULL
factors	NULL
of	NULL
the	NULL
Pax	NULL
family	NULL
recognize	NULL
their	NULL
target	NULL
genes	NULL
via	NULL
the	NULL
DNA	NULL
binding	NULL
function	NULL
of	NULL
the	NULL
paired	NULL
domain	NULL
(	NULL
Chalepakis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Treisman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Detailed	NULL
mutational	NULL
analysis	NULL
of	NULL
BSAP	NULL
(	NULL
Pax-5	NULL
)	NULL
revealed	NULL
a	NULL
bipartite	NULL
structure	NULL
of	NULL
the	NULL
paired	NULL
domain	NULL
and	NULL
its	NULL
binding	NULL
sites	NULL
,	NULL
and	NULL
led	NULL
to	NULL
the	NULL
identification	NULL
of	NULL
a	NULL
consensus	NULL
recognition	NULL
sequence	NULL
bound	NULL
by	NULL
all	NULL
Pax	NULL
proteins	NULL
analysed	NULL
to	NULL
date	NULL
(	NULL
Czerny	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Initially	NULL
,	NULL
Pax	NULL
proteins	NULL
were	NULL
assumed	NULL
to	NULL
be	NULL
transcription	NULL
factors	NULL
solely	NULL
based	NULL
on	NULL
their	NULL
nuclear	NULL
localization	NULL
(	NULL
Bopp	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
and	NULL
DNA	NULL
binding	NULL
potential	NULL
.	NULL

Subsequently	NULL
,	NULL
cell	NULL
transfection	NULL
experiments	NULL
demonstrated	NULL
transcriptional	NULL
activity	NULL
for	NULL
all	NULL
members	NULL
of	NULL
the	NULL
Pax	NULL
protein	NULL
family	NULL
analysed	NULL
:	NULL
Pax-1	NULL
(	NULL
Chalepakis	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
Pax-2	NULL
(	NULL
Fickenscher	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
Pax-3	NULL
(	NULL
Chalepakis	NULL
et	NULL
al	NULL
.	NULL

;	NULL
1994	NULL
)	NULL
,	NULL
BSAP	NULL
(	NULL
Pax-5	NULL
)	NULL
(	NULL
Barberis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
Pax-6	NULL
(	NULL
Glaser	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Czerny	NULL
and	NULL
Busslinger	NULL
,	NULL
1995	NULL
)	NULL
,	NULL
Pax-7	NULL
(	NULL
Schafer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
and	NULL
Pax-8	NULL
(	NULL
Zannini	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Kozmik	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Most	NULL
Pax	NULL
proteins	NULL
end	NULL
in	NULL
distinct	NULL
serine/threonine/proline-rich	NULL
sequences	NULL
(	NULL
PST-rich	NULL
)	NULL
which	NULL
are	NULL
thought	NULL
to	NULL
constitute	NULL
transactivation	NULL
domains	NULL
,	NULL
since	NULL
their	NULL
elimination	NULL
by	NULL
gross	NULL
deletion	NULL
(	NULL
Fickenscher	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Chalepakis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Czerny	NULL
and	NULL
Busslinger	NULL
,	NULL
1995	NULL
)	NULL
or	NULL
replacement	NULL
by	NULL
alternative	NULL
splicing	NULL
(	NULL
Kozmik	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
reduces	NULL
or	NULL
abrogates	NULL
the	NULL
transactivation	NULL
function	NULL
of	NULL
Pax	NULL
proteins	NULL
.	NULL

However	NULL
,	NULL
none	NULL
of	NULL
these	NULL
transactivation	NULL
domains	NULL
has	NULL
been	NULL
defined	NULL
and	NULL
characterized	NULL
in	NULL
detail	NULL
by	NULL
in	NULL
vitro	NULL
mutagenesis	NULL
,	NULL
yet	NULL
detailed	NULL
knowledge	NULL
of	NULL
the	NULL
transactivation	NULL
function	NULL
will	NULL
be	NULL
required	NULL
to	NULL
further	NULL
our	NULL
understanding	NULL
of	NULL
how	NULL
transcription	NULL
factors	NULL
of	NULL
the	NULL
Pax	NULL
family	NULL
regulate	NULL
gene	NULL
expression	NULL
during	NULL
development	NULL
and	NULL
differentiation	NULL
.	NULL

Here	NULL
we	NULL
present	NULL
a	NULL
detailed	NULL
structure-function	NULL
analysis	NULL
of	NULL
BSAP	NULL
(	NULL
Pax-5	NULL
)	NULL
which	NULL
has	NULL
led	NULL
to	NULL
the	NULL
identification	NULL
of	NULL
a	NULL
potent	NULL
transactivation	NULL
domain	NULL
of	NULL
55	NULL
amino	NULL
acids	NULL
located	NULL
within	NULL
the	NULL
C-terminal	NULL
PST-rich	NULL
sequences	NULL
.	NULL

This	NULL
domain	NULL
exerts	NULL
its	NULL
activating	NULL
function	NULL
from	NULL
a	NULL
promoter	NULL
as	NULL
well	NULL
as	NULL
an	NULL
enhancer	NULL
position	NULL
and	NULL
is	NULL
subject	NULL
to	NULL
strong	NULL
negative	NULL
regulation	NULL
by	NULL
adjacent	NULL
sequences	NULL
from	NULL
the	NULL
extreme	NULL
C-terminus	NULL
.	NULL

Interestingly	NULL
,	NULL
a	NULL
naturally	NULL
occurring	NULL
frameshift	NULL
mutation	NULL
which	NULL
inactivates	NULL
the	NULL
transactivation	NULL
domain	NULL
of	NULL
BSAP	NULL
was	NULL
identified	NULL
in	NULL
one	NULL
PAX-5	NULL
allele	NULL
of	NULL
a	NULL
B-lymphoid	NULL
cell	NULL
line	NULL
derived	NULL
from	NULL
a	NULL
patent	NULL
with	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
(	NULL
ALL	NULL
)	NULL
.	NULL

Comparative	NULL
studies	NULL
furthermore	NULL
revealed	NULL
that	NULL
both	NULL
the	NULL
transactivating	NULL
sequences	NULL
and	NULL
the	NULL
adjacent	NULL
inhibitory	NULL
domain	NULL
are	NULL
structurally	NULL
and	NULL
functionally	NULL
conserved	NULL
in	NULL
all	NULL
members	NULL
of	NULL
the	NULL
Pax	NULL
protein	NULL
subfamily	NULL
consisting	NULL
of	NULL
the	NULL
mammalian	NULL
Pax-2	NULL
,	NULL
Pax-5	NULL
,	NULL
Pax-8	NULL
,	NULL
the	NULL
zebrafish	NULL
Pax-b	NULL
and	NULL
the	NULL
distantly	NULL
related	NULL
sea	NULL
urchin	NULL
Pax-258	NULL
1971	NULL
P.Dorfler	NULL
and	NULL
M.Busslinger	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Activation	NULL
of	NULL
reporter	NULL
gene	NULL
transcription	NULL
by	NULL
endogenous	NULL
and	NULL
exogenous	NULL
BSAP	NULL
.	NULL

Three	NULL
copies	NULL
of	NULL
the	NULL
high-affinity	NULL
BSAP	NULL
binding	NULL
site	NULL
CD19-2	NULL
(	NULL
A-ins	NULL
)	NULL
(	NULL
Czerny	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
or	NULL
a	NULL
mutant	NULL
derivative	NULL
differing	NULL
by	NULL
two	NULL
nucleotide	NULL
substitutions	NULL
,	NULL
were	NULL
inserted	NULL
upstream	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
of	NULL
the	NULL
-globin	NULL
gene	NULL
in	NULL
OVEC-S	NULL
to	NULL
generate	NULL
the	NULL
reporter	NULL
constructs	NULL
glob-CD19	NULL
and	NULL
glob-CD19mut	NULL
,	NULL
respectively	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
methods	NULL
)	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
these	NULL
reporter	NULL
constructs	NULL
contained	NULL
the	NULL
SV40	NULL
enhancer	NULL
(	NULL
+E	NULL
)	NULL
downstream	NULL
of	NULL
the	NULL
B-globin	NULL
gene	NULL
.	NULL

The	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
or	NULL
mutant	NULL
(	NULL
mut	NULL
)	NULL
reporter	NULL
constructs	NULL
(	NULL
9	NULL
pug	NULL
)	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
cells	NULL
of	NULL
the	NULL
murine	NULL
B	NULL
cell	NULL
line	NULL
M12.4.1	NULL
together	NULL
with	NULL
the	NULL
reference	NULL
gene	NULL
OVEC-Ref	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
(	NULL
Westin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
-globin	NULL
reporter	NULL
genes	NULL
was	NULL
monitored	NULL
by	NULL
RNase	NULL
protection	NULL
assay	NULL
.	NULL

Cells	NULL
of	NULL
the	NULL
murine	NULL
plasma	NULL
cell	NULL
line	NULL
SP2/0	NULL
were	NULL
additionally	NULL
transfected	NULL
with	NULL
a	NULL
BSAP	NULL
expression	NULL
plasmid	NULL
or	NULL
the	NULL
empty	NULL
expression	NULL
vector	NULL
pKW2T	NULL
(	NULL
2.5	NULL
ug	NULL
each	NULL
)	NULL
.	NULL

proteins	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
a	NULL
subset	NULL
of	NULL
Pax	NULL
proteins	NULL
is	NULL
determined	NULL
by	NULL
a	NULL
C-terminal	NULL
regulatory	NULL
module	NULL
consisting	NULL
of	NULL
activating	NULL
and	NULL
inhibitory	NULL
sequences	NULL
.	NULL

Results	NULL
Development	NULL
of	NULL
a	NULL
reporter	NULL
system	NULL
to	NULL
study	NULL
the	NULL
transactivation	NULL
function	NULL
of	NULL
BSAP	NULL
The	NULL
promoters	NULL
of	NULL
the	NULL
BSAP-regulated	NULL
gene	NULL
CD19	NULL
and	NULL
the	NULL
putative	NULL
target	NULL
genes	NULL
bik	NULL
,	NULL
V	NULL
,	NULL
,	NULL
;	NULL
and	NULL
Ig	NULL
are	NULL
weakly	NULL
active	NULL
in	NULL
transiently	NULL
transfected	NULL
B	NULL
cells	NULL
and	NULL
can	NULL
only	NULL
be	NULL
minimally	NULL
stimulated	NULL
by	NULL
ectopic	NULL
BSAP	NULL
expression	NULL
in	NULL
heterologous	NULL
cell	NULL
types	NULL
(	NULL
reviewed	NULL
by	NULL
Busslinger	NULL
and	NULL
Urbdnek	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

Common	NULL
to	NULL
all	NULL
of	NULL
these	NULL
genes	NULL
is	NULL
the	NULL
fact	NULL
that	NULL
their	NULL
promoters	NULL
do	NULL
not	NULL
contain	NULL
a	NULL
TATA	NULL
box	NULL
and	NULL
consequently	NULL
initiate	NULL
transcription	NULL
at	NULL
heterogeneous	NULL
start	NULL
sites	NULL
.	NULL

These	NULL
promoters	NULL
could	NULL
therefore	NULL
not	NULL
be	NULL
used	NULL
to	NULL
generate	NULL
efficient	NULL
reporter	NULL
constructs	NULL
for	NULL
investigating	NULL
the	NULL
transactivation	NULL
function	NULL
of	NULL
BSAP	NULL
in	NULL
cell	NULL
transfection	NULL
experiments	NULL
.	NULL

Hence	NULL
,	NULL
we	NULL
created	NULL
an	NULL
artificial	NULL
promoter	NULL
by	NULL
inserting	NULL
three	NULL
copies	NULL
of	NULL
a	NULL
high-affinity	NULL
BSAP	NULL
binding	NULL
site	NULL
derived	NULL
from	NULL
the	NULL
CD19	NULL
promoter	NULL
[	NULL
CD19-2	NULL
(	NULL
A-ins	NULL
)	NULL
]	NULL
upstream	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
of	NULL
the	NULL
rabbit	NULL
B-globin	NULL
gene	NULL
(	NULL
Figure	NULL
1	NULL
;	NULL
wt	NULL
reporter	NULL
glob-CD19	NULL
)	NULL
.	NULL

This	NULL
reporter	NULL
construct	NULL
was	NULL
transiently	NULL
transfected	NULL
into	NULL
several	NULL
B	NULL
cell	NULL
lines	NULL
together	NULL
with	NULL
the	NULL
internal	NULL
reference	NULL
gene	NULL
OVEC-Ref	NULL
containing	NULL
a	NULL
deletion	NULL
in	NULL
the	NULL
B-globin	NULL
leader	NULL
sequences	NULL
(	NULL
Westin	NULL
ef	NULL
a/	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
,	NULL
and	NULL
1972	NULL
-globin	NULL
transcripts	NULL
were	NULL
detected	NULL
by	NULL
RNase	NULL
protection	NULL
analysis	NULL
.	NULL

As	NULL
illustrated	NULL
in	NULL
Figure	NULL
1	NULL
,	NULL
this	NULL
reporter	NULL
gene	NULL
was	NULL
efficiently	NULL
transcribed	NULL
in	NULL
the	NULL
murine	NULL
B	NULL
cell	NULL
line	NULL
M12.4.1	NULL
most	NULL
probably	NULL
due	NULL
to	NULL
activation	NULL
by	NULL
endogenous	NULL
BSAP	NULL
.	NULL

To	NULL
directly	NULL
demonstrate	NULL
-dependent	NULL
regulation	NULL
,	NULL
we	NULL
mutated	NULL
the	NULL
reporter	NULL
gene	NULL
by	NULL
introducing	NULL
two	NULL
point	NULL
mutations	NULL
into	NULL
each	NULL
BSAP	NULL
recognition	NULL
sequence	NULL
(	NULL
reporter	NULL
glob-CD19mut	NULL
,	NULL
Figure	NULL
1	NULL
)	NULL
which	NULL
interfered	NULL
with	NULL
protein	NULL
binding	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
P.Dorfler	NULL
,	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

These	NULL
mutations	NULL
indeed	NULL
prevented	NULL
activation	NULL
of	NULL
reporter	NULL
gene	NULL
transcription	NULL
by	NULL
BSAP	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

Analogous	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
BSAP-negative	NULL
plasma	NULL
cell	NULL
lines	NULL
by	NULL
co-transfection	NULL
of	NULL
the	NULL
two	NULL
reporter	NULL
plasmids	NULL
with	NULL
a	NULL
BSAP	NULL
expression	NULL
vector	NULL
.	NULL

As	NULL
shown	NULL
for	NULL
the	NULL
murine	NULL
plasma	NULL
cell	NULL
line	NULL
SP2/0	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
,	NULL
transcription	NULL
of	NULL
the	NULL
wt	NULL
reporter	NULL
gene	NULL
was	NULL
strongly	NULL
and	NULL
specifically	NULL
activated	NULL
by	NULL
BSAP	NULL
compared	NULL
with	NULL
expression	NULL
of	NULL
the	NULL
mutant	NULL
reporter	NULL
gene	NULL
or	NULL
with	NULL
the	NULL
basal-level	NULL
expression	NULL
observed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
empty	NULL
expression	NULL
vector	NULL
pKW2T	NULL
.	NULL

In	NULL
B	NULL
cells	NULL
,	NULL
strong	NULL
transactivation	NULL
by	NULL
endogenous	NULL
BSAP	NULL
was	NULL
reproducibly	NULL
seen	NULL
only	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
heterologous	NULL
enhancer	NULL
(	NULL
SV40	NULL
enhancer	NULL
)	NULL
inserted	NULL
downstream	NULL
of	NULL
the	NULL
fB-globin	NULL
reporter	NULL
gene	NULL
.	NULL

Such	NULL
an	NULL
enhancer	NULL
was	NULL
not	NULL
necessary	NULL
for	NULL
activation	NULL
in	NULL
the	NULL
plasma	NULL
cell	NULL
line	NULL
SP2/0	NULL
(	NULL
lanes	NULL
+E	NULL
in	NULL
Figure	NULL
1	NULL
)	NULL
and	NULL
thus	NULL
all	NULL
further	NULL
analyses	NULL
in	NULL
plasma	NULL
cells	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
wt	NULL
reporter	NULL
gene	NULL
glob-CD19	NULL
lacking	NULL
the	NULL
SV40	NULL
enhancer	NULL
.	NULL

Moreover	NULL
,	NULL
analysis	NULL
of	NULL
five	NULL
different	NULL
plasma	NULL
cell	NULL
lines	NULL
demonstrated	NULL
that	NULL
the	NULL
transactivation	NULL
potential	NULL
of	NULL
BSAP	NULL
was	NULL
highest	NULL
in	NULL
SP2/0	NULL
cells	NULL
(	NULL
P.Dorfler	NULL
,	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
SP2/0	NULL
cells	NULL
were	NULL
initially	NULL
used	NULL
to	NULL
define	NULL
the	NULL
transactivation	NULL
function	NULL
of	NULL
BSAP	NULL
.	NULL

The	NULL
C-terminal	NULL
sequences	NULL
of	NULL
BSAP	NULL
harbour	NULL
a	NULL
potent	NULL
transactivation	NULL
domain	NULL
which	NULL
is	NULL
active	NULL
from	NULL
promoter	NULL
and	NULL
enhancer	NULL
positions	NULL
To	NULL
elucidate	NULL
the	NULL
BSAP	NULL
domain	NULL
(	NULL
s	NULL
)	NULL
required	NULL
for	NULL
transactiva-tion	NULL
,	NULL
we	NULL
generated	NULL
a	NULL
series	NULL
of	NULL
C-terminal	NULL
and	NULL
internal	NULL
deletion	NULL
mutants	NULL
(	NULL
Figure	NULL
2	NULL
,	NULL
constructs	NULL
B2-B18	NULL
)	NULL
which	NULL
we	NULL
analysed	NULL
by	NULL
transient	NULL
transfection	NULL
in	NULL
SP2/0	NULL
cells	NULL
,	NULL
utilizing	NULL
the	NULL
above	NULL
described	NULL
reporter	NULL
system	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
up	NULL
to	NULL
33	NULL
amino	NULL
acids	NULL
from	NULL
the	NULL
C-terminus	NULL
of	NULL
BSAP	NULL
(	NULL
constructs	NULL
B2-B4	NULL
)	NULL
did	NULL
not	NULL
reduce	NULL
the	NULL
transactivation	NULL
potential	NULL
compared	NULL
with	NULL
the	NULL
full-length	NULL
protein	NULL
(	NULL
B1	NULL
;	NULL
Figure	NULL
3A	NULL
)	NULL
.	NULL

However	NULL
,	NULL
deletion	NULL
of	NULL
additional	NULL
13	NULL
amino	NULL
acids	NULL
in	NULL
mutant	NULL
B5	NULL
drastically	NULL
reduced	NULL
BSAP-dependent	NULL
transcription	NULL
(	NULL
Figure	NULL
3A	NULL
)	NULL
.	NULL

The	NULL
same	NULL
reduction	NULL
was	NULL
also	NULL
observed	NULL
for	NULL
all	NULL
further	NULL
C-terminal	NULL
deletion	NULL
mutants	NULL
(	NULL
B6-B9	NULL
;	NULL
Figure	NULL
3A	NULL
)	NULL
.	NULL

As	NULL
this	NULL
result	NULL
could	NULL
be	NULL
explained	NULL
by	NULL
failed	NULL
synthesis	NULL
or	NULL
instability	NULL
of	NULL
the	NULL
truncated	NULL
BSAP	NULL
peptides	NULL
,	NULL
we	NULL
analysed	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
the	NULL
same	NULL
transfected	NULL
cells	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
3A	NULL
,	NULL
all	NULL
BSAP	NULL
polypeptides	NULL
were	NULL
expressed	NULL
at	NULL
comparable	NULL
levels	NULL
,	NULL
thus	NULL
indicating	NULL
that	NULL
the	NULL
observed	NULL
differences	NULL
in	NULL
transactivation	NULL
did	NULL
not	NULL
result	NULL
from	NULL
abnormal	NULL
expression	NULL
of	NULL
the	NULL
mutant	NULL
proteins	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
immuno-cytochemistry	NULL
with	NULL
anti-paired	NULL
domain	NULL
antibodies	NULL
demonstrated	NULL
that	NULL
transcriptionally	NULL
inactive	NULL
deletion	NULL
mutants	NULL
such	NULL
as	NULL
B9	NULL
were	NULL
localized	NULL
in	NULL
the	NULL
nucleus	NULL
like	NULL
the	NULL
full-length	NULL
protein	NULL
(	NULL
B1	NULL
;	NULL
Figure	NULL
3C	NULL
)	NULL
.	NULL

The	NULL
immunofluorescence	NULL
analysis	NULL
was	NULL
performed	NULL
with	NULL
transiently	NULL
transfected	NULL
murine	NULL
COP-8	NULL
fibroblasts	NULL
(	NULL
Tyndall	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1981	NULL
)	NULL
which	NULL
allow	NULL
a	NULL
better	NULL
distinction	NULL
between	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
compartments	NULL
paired	NULL
octa-	NULL
-	NULL
homeodomain	NULL
Ser/Thr/Pro-fich	NULL
domains	NULL
domain	NULL
peptide	NULL
-	NULL
homology	NULL
\_	NULL
2	NULL
$	NULL
¢	NULL
$	NULL
$	NULL
_	NULL
g	NULL
N	NULL
ssar	NULL
|_	NULL
R	NULL
<	NULL
_	NULL
]	NULL
_	NULL
_-	NULL
)	NULL
)	NULL
3	NULL
)	NULL
391	NULL
B2	NULL
arg	NULL
B3	NULL
369	NULL
B4	NULL
ase	NULL
B5	NULL
345	NULL
B6	NULL
ase	NULL
B7	NULL
azo	NULL
B8	NULL
302	NULL
B9	NULL
2	NULL
Bio	NULL
180	NULL
Ll	NULL
2299s	NULL
_	NULL
20	NULL
ao	NULL
B1	NULL
.	NULL

«	NULL
--	NULL
-	NULL
*M	NULL
__	NULL
,	NULL
B12	NULL
-	NULL
«	NULL
--	NULL
-	NULL
R	NULL
--	NULL
--	NULL
-S13	NULL
B	NULL
33334	NULL
14	NULL
.	NULL

«	NULL
--	NULL
-	NULL
222222	NULL
y	NULL
,	NULL
f	NULL
___	NULL
,	NULL
B1§	NULL
.	NULL

«	NULL
--	NULL
-	NULL
___	NULL
367	NULL
B16	NULL
.	NULL

<	NULL
--	NULL
-B17	NULL
.	NULL

<	NULL
--	NULL
-B18	NULL
<	NULL
--	NULL
--	NULL
--	NULL
--	NULL
_	NULL
--	NULL
--	NULL
--	NULL
R	NULL
GAL	NULL
4	NULL
&	NULL
ee	NULL
61	NULL
-	NULL
Sms	NULL
Tonya	NULL
g2	NULL
-	NULL
ast	NULL
___	NULL
ase	NULL
319	NULL
as	NULL
-	NULL
sSssmmmmmamsy	NULL
1203	NULL
304	NULL
358	NULL
g4	NULL
-	NULL
Sms	NULL
304	NULL
65	NULL
|	NULL
sss	NULL
;	NULL
an	NULL
304	NULL
ase	NULL
66	NULL
.	NULL

--	NULL
-	NULL
GAL	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Schematic	NULL
diagram	NULL
of	NULL
BSAP	NULL
deletion	NULL
mutants	NULL
and	NULL
chimeric	NULL
GAL4-BSAP	NULL
proteins	NULL
.	NULL

The	NULL
structural	NULL
organization	NULL
of	NULL
human	NULL
BSAP	NULL
(	NULL
B1	NULL
)	NULL
is	NULL
shown	NULL
together	NULL
with	NULL
the	NULL
extent	NULL
of	NULL
the	NULL
various	NULL
deletions	NULL
engineered	NULL
into	NULL
the	NULL
mutant	NULL
BSAP	NULL
proteins	NULL
B2-B18	NULL
.	NULL

Numbers	NULL
refer	NULL
to	NULL
the	NULL
corresponding	NULL
amino	NULL
acid	NULL
positions	NULL
of	NULL
human	NULL
BSAP	NULL
(	NULL
Adams	NULL
et	NULL
al..	NULL
1992	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
the	NULL
yeast	NULL
GAL4	NULL
protein	NULL
(	NULL
amino	NULL
acids	NULL
1-147	NULL
;	NULL
indicated	NULL
by	NULL
a	NULL
hatched	NULL
bar	NULL
)	NULL
was	NULL
fused	NULL
to	NULL
C-terminal	NULL
sequences	NULL
of	NULL
BSAP	NULL
in	NULL
the	NULL
chimeric	NULL
proteins	NULL
G1-G6	NULL
.	NULL

A	NULL
wavy	NULL
line	NULL
indicates	NULL
a	NULL
shift	NULL
in	NULL
reading	NULL
frame	NULL
near	NULL
the	NULL
C-terminus	NULL
of	NULL
protein	NULL
G6	NULL
(	NULL
for	NULL
sequence	NULL
see	NULL
Figure	NULL
9	NULL
)	NULL
.	NULL

For	NULL
generation	NULL
of	NULL
the	NULL
different	NULL
constructs	NULL
see	NULL
Materials	NULL
and	NULL
methods	NULL
.	NULL

than	NULL
plasma	NULL
cells	NULL
.	NULL

These	NULL
control	NULL
experiments	NULL
thus	NULL
indicated	NULL
that	NULL
the	NULL
reduction	NULL
in	NULL
reporter	NULL
gene	NULL
transcription	NULL
was	NULL
indeed	NULL
due	NULL
to	NULL
loss	NULL
of	NULL
the	NULL
transactivation	NULL
function	NULL
in	NULL
the	NULL
BSAP	NULL
deletion	NULL
mutants	NULL
.	NULL

The	NULL
C-terminal	NULL
deletion	NULL
analysis	NULL
therefore	NULL
placed	NULL
the	NULL
C-terminal	NULL
boundary	NULL
of	NULL
the	NULL
BSAP	NULL
transactivation	NULL
domain	NULL
near	NULL
amino	NULL
acid	NULL
358	NULL
(	NULL
construct	NULL
B4	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
delimit	NULL
the	NULL
N-terminal	NULL
boundary	NULL
of	NULL
the	NULL
BSAP	NULL
transactivation	NULL
domain	NULL
,	NULL
we	NULL
generated	NULL
an	NULL
internal	NULL
deletion	NULL
by	NULL
fusing	NULL
the	NULL
PST-rich	NULL
C-terminal	NULL
sequences	NULL
at	NULL
codon	NULL
281	NULL
to	NULL
the	NULL
paired	NULL
domain	NULL
which	NULL
on	NULL
its	NULL
own	NULL
lacks	NULL
any	NULL
transactivation	NULL
function	NULL
(	NULL
construct	NULL
B18	NULL
)	NULL
.	NULL

Although	NULL
this	NULL
large	NULL
internal	NULL
deletion	NULL
removed	NULL
the	NULL
conserved	NULL
octapeptide	NULL
motif	NULL
,	NULL
the	NULL
homeodomain	NULL
homology	NULL
region	NULL
and	NULL
additional	NULL
serine/threonine-rich	NULL
sequences	NULL
(	NULL
see	NULL
Figure	NULL
2	NULL
)	NULL
,	NULL
the	NULL
respective	NULL
mutant	NULL
protein	NULL
B1O	NULL
exhibited	NULL
similar	NULL
transcriptional	NULL
activity	NULL
as	NULL
full-length	NULL
BSAP	NULL
(	NULL
Figure	NULL
3B	NULL
)	NULL
.	NULL

Successive	NULL
deletion	NULL
of	NULL
amino	NULL
acids	NULL
281-319	NULL
in	NULL
constructs	NULL
B11	NULL
and	NULL
B12	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
transactivation	NULL
function	NULL
of	NULL
BSAP	NULL
in	NULL
SP2/0	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
further	NULL
deletion	NULL
of	NULL
the	NULL
PST-rich	NULL
sequences	NULL
gradually	NULL
decreased	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
mutant	NULL
proteins	NULL
,	NULL
whilst	NULL
leaving	NULL
their	NULL
expression	NULL
level	NULL
unaltered	NULL
(	NULL
constructs	NULL
B13-15	NULL
;	NULL
Figure	NULL
2B	NULL
)	NULL
.	NULL

These	NULL
data	NULL
therefore	NULL
map	NULL
the	NULL
N-terminal	NULL
boundary	NULL
of	NULL
the	NULL
transactivation	NULL
domain	NULL
close	NULL
to	NULL
amino	NULL
acid	NULL
319	NULL
(	NULL
construct	NULL
B12	NULL
)	NULL
.	NULL

The	NULL
combined	NULL
results	NULL
of	NULL
the	NULL
N-	NULL
and	NULL
C-terminal	NULL
Transactivation	NULL
properties	NULL
of	NULL
BSAP	NULL
(	NULL
Pax-5	NULL
)	NULL
deletion	NULL
analyses	NULL
predict	NULL
that	NULL
the	NULL
sequences	NULL
between	NULL
amino	NULL
acids	NULL
319	NULL
and	NULL
358	NULL
constitute	NULL
the	NULL
minimal	NULL
transactivation	NULL
domain	NULL
of	NULL
BSAP	NULL
.	NULL

Indeed	NULL
,	NULL
this	NULL
40	NULL
amino	NULL
acid	NULL
sequence	NULL
linked	NULL
to	NULL
the	NULL
paired	NULL
domain	NULL
(	NULL
construct	NULL
B17	NULL
)	NULL
activated	NULL
reporter	NULL
gene	NULL
transcription	NULL
as	NULL
efficiently	NULL
as	NULL
full-length	NULL
BSAP	NULL
(	NULL
Figure	NULL
3B	NULL
)	NULL
in	NULL
SP2/0	NULL
cells	NULL
.	NULL

We	NULL
next	NULL
investigated	NULL
whether	NULL
transactivation	NULL
from	NULL
a	NULL
promoter	NULL
or	NULL
enhancer	NULL
position	NULL
would	NULL
depend	NULL
on	NULL
the	NULL
same	NULL
or	NULL
different	NULL
BSAP	NULL
sequences	NULL
.	NULL

A	NULL
thymidine	NULL
kinase	NULL
(	NULL
TK	NULL
)	NULL
-luciferase	NULL
gene	NULL
containing	NULL
three	NULL
BS	NULL
AP	NULL
binding	NULL
sites	NULL
inserted	NULL
2	NULL
kb	NULL
downstream	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
of	NULL
the	NULL
TK	NULL
promoter	NULL
(	NULL
Czerny	NULL
and	NULL
Busslinger	NULL
,	NULL
1995	NULL
)	NULL
was	NULL
co-transfected	NULL
into	NULL
SP2/0	NULL
cells	NULL
together	NULL
with	NULL
expression	NULL
plasmids	NULL
directing	NULL
the	NULL
synthesis	NULL
of	NULL
full-length	NULL
or	NULL
mutant	NULL
BSAP	NULL
proteins	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
minimal	NULL
transactivation	NULL
domain	NULL
present	NULL
in	NULL
mutant	NULL
B17	NULL
was	NULL
already	NULL
sufficient	NULL
to	NULL
activate	NULL
luciferase	NULL
expression	NULL
as	NULL
effectively	NULL
as	NULL
full-length	NULL
BSAP	NULL
(	NULL
B1	NULL
)	NULL
(	NULL
Figure	NULL
4	NULL
)	NULL
.	NULL

In	NULL
both	NULL
cases	NULL
,	NULL
transcription	NULL
of	NULL
the	NULL
luciferase	NULL
gene	NULL
was	NULL
increased	NULL
~4-fold	NULL
relative	NULL
to	NULL
the	NULL
basal	NULL
activity	NULL
of	NULL
the	NULL
TK	NULL
promoter	NULL
measured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
empty	NULL
expression	NULL
vector	NULL
pKW2T	NULL
.	NULL

We	NULL
conclude	NULL
therefore	NULL
that	NULL
a	NULL
minimal	NULL
transactivation	NULL
domain	NULL
of	NULL
40	NULL
amino	NULL
acids	NULL
located	NULL
in	NULL
the	NULL
C-terminal	NULL
region	NULL
of	NULL
BSAP	NULL
is	NULL
sufficient	NULL
in	NULL
SP2/0	NULL
cells	NULL
to	NULL
mediate	NULL
transcriptional	NULL
activation	NULL
both	NULL
from	NULL
promoter	NULL
and	NULL
enhancer	NULL
positions	NULL
.	NULL

The	NULL
cell	NULL
line	NULL
REH	NULL
derived	NULL
from	NULL
an	NULL
ALL	NULL
patient	NULL
contains	NULL
a	NULL
frameshift	NULL
mutation	NULL
in	NULL
one	NULL
PAX-5	NULL
allele	NULL
which	NULL
eliminates	NULL
the	NULL
transactivation	NULL
function	NULL
of	NULL
BSAP	NULL
Screening	NULL
of	NULL
established	NULL
B-lymphoid	NULL
cell	NULL
lines	NULL
for	NULL
BSAP	NULL
expression	NULL
revealed	NULL
a	NULL
truncated	NULL
form	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
in	NULL
the	NULL
cell	NULL
line	NULL
REH	NULL
which	NULL
was	NULL
originally	NULL
established	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
(	NULL
ALL	NULL
)	NULL
(	NULL
Rosenfeld	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1977	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
REH	NULL
and	NULL
control	NULL
BJA-B	NULL
cells	NULL
were	NULL
subjected	NULL
to	NULL
EMSA	NULL
analysis	NULL
with	NULL
a	NULL
paired	NULL
domain	NULL
binding	NULL
probe	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
5A	NULL
,	NULL
REH	NULL
cells	NULL
synthesize	NULL
both	NULL
full-length	NULL
BSAP	NULL
and	NULL
a	NULL
truncated	NULL
polypeptide	NULL
in	NULL
similar	NULL
amounts	NULL
,	NULL
suggesting	NULL
that	NULL
one	NULL
PAX-5	NULL
allele	NULL
may	NULL
be	NULL
mutated	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

BSAP	NULL
cDNA	NULL
was	NULL
therefore	NULL
amplified	NULL
by	NULL
PCR	NULL
from	NULL
REH	NULL
cells	NULL
,	NULL
cloned	NULL
into	NULL
the	NULL
expression	NULL
vector	NULL
pKW10	NULL
(	NULL
Adams	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
and	NULL
analysed	NULL
for	NULL
protein	NULL
expression	NULL
in	NULL
transfected	NULL
COP-8	NULL
fibroblasts	NULL
.	NULL

Several	NULL
cDNAs	NULL
were	NULL
isolated	NULL
that	NULL
encoded	NULL
either	NULL
full-length	NULL
or	NULL
truncated	NULL
BSAP	NULL
proteins	NULL
,	NULL
as	NULL
exemplified	NULL
by	NULL
clones	NULL
1	NULL
and	NULL
2	NULL
(	NULL
Figure	NULL
5A	NULL
)	NULL
.	NULL

DNA	NULL
sequencing	NULL
of	NULL
clone	NULL
1	NULL
revealed	NULL
that	NULL
an	NULL
additional	NULL
C	NULL
residue	NULL
was	NULL
inserted	NULL
into	NULL
a	NULL
string	NULL
of	NULL
seven	NULL
cytosines	NULL
at	NULL
positions	NULL
1032-1038	NULL
of	NULL
the	NULL
BSAP	NULL
cDNA	NULL
(	NULL
Adams	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

This	NULL
single	NULL
nucleotide	NULL
insertion	NULL
shifts	NULL
the	NULL
reading	NULL
frame	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
minimal	NULL
transactivation	NULL
domain	NULL
,	NULL
thus	NULL
resulting	NULL
in	NULL
premature	NULL
termination	NULL
of	NULL
translation	NULL
after	NULL
18	NULL
additional	NULL
amino	NULL
acids	NULL
(	NULL
Figure	NULL
5C	NULL
)	NULL
.	NULL

The	NULL
truncated	NULL
protein	NULL
of	NULL
clone	NULL
1	NULL
consequently	NULL
failed	NULL
to	NULL
activate	NULL
BSAP-dependent	NULL
reporter	NULL
gene	NULL
transcription	NULL
,	NULL
although	NULL
it	NULL
was	NULL
as	NULL
efficiently	NULL
synthesized	NULL
in	NULL
transfected	NULL
SP2/0	NULL
cells	NULL
as	NULL
the	NULL
wild-type	NULL
protein	NULL
of	NULL
clone	NULL
2	NULL
(	NULL
Figure	NULL
5B	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
transcripts	NULL
of	NULL
the	NULL
BSAP	NULL
target	NULL
gene	NULL
CD19	NULL
are	NULL
markedly	NULL
reduced	NULL
in	NULL
abundance	NULL
in	NULL
REH	NULL
cells	NULL
compared	NULL
with	NULL
most	NULL
other	NULL
human	NULL
-	NULL
B	NULL
cell	NULL
lines	NULL
(	NULL
Kozmik	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
,	NULL
which	NULL
may	NULL
reflect	NULL
either	NULL
the	NULL
lower	NULL
level	NULL
of	NULL
transactivation-competent	NULL
BSAP	NULL
and/or	NULL
negative	NULL
interference	NULL
by	NULL
the	NULL
mutant	NULL
protein	NULL
in	NULL
REH	NULL
cells	NULL
.	NULL

This	NULL
finding	NULL
therefore	NULL
suggests	NULL
that	NULL
the	NULL
minimal	NULL
1973	NULL
P.Dorfler	NULL
and	NULL
M.Busslinger	NULL
}	NULL
_	NULL
A	NULL
t	NULL
1	NULL
R	NULL
3	NULL
4	NULL
560	NULL
B8	NULL
t	NULL
s	NULL
9	NULL
&	NULL
*	NULL
p	NULL
g	NULL
»	NULL
INA	NULL
«	NULL
t	NULL
I	NULL
this	NULL
comme	NULL
wllit	NULL
``	NULL
up	NULL
FITC	NULL
DAPI	NULL
reporter	NULL
reference	NULL
_	NULL
B	NULL
5	NULL
1	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
1617185	NULL
pen	NULL
@	NULL
ue	NULL
ww	NULL
--	NULL
same	NULL
|	NULL
qemey	NULL
|	NULL
query	NULL
«	NULL
ome	NULL
.	NULL

wren	NULL
.	NULL

ime	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
minimal	NULL
transactivation	NULL
domain	NULL
of	NULL
BSAP	NULL
by	NULL
analysis	NULL
of	NULL
deletion	NULL
mutants	NULL
in	NULL
SP2/0	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
C-terminal	NULL
deletions	NULL
of	NULL
BSAP	NULL
.	NULL

Cells	NULL
of	NULL
the	NULL
murine	NULL
plasma	NULL
cell	NULL
line	NULL
SP2/0	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
glob-CD19	NULL
reporter	NULL
gene	NULL
(	NULL
7	NULL
ug	NULL
)	NULL
,	NULL
OVEC-ref	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
and	NULL
expression	NULL
plasmids	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
directing	NULL
the	NULL
synthesis	NULL
of	NULL
full-length	NULL
BSAP	NULL
(	NULL
B1	NULL
)	NULL
or	NULL
the	NULL
C-terminal	NULL
deletion	NULL
mutants	NULL
B2-B9	NULL
.	NULL

The	NULL
empty	NULL
expression	NULL
vector	NULL
pKW2T	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
.	NULL

Cytoplasmic	NULL
RNA	NULL
of	NULL
transfected	NULL
cells	NULL
was	NULL
analysed	NULL
for	NULL
B-globin	NULL
transcripts	NULL
by	NULL
RNase	NULL
protection	NULL
assay	NULL
.	NULL

Protein	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
the	NULL
nuclear	NULL
pellet	NULL
of	NULL
the	NULL
same	NULL
transfected	NULL
cells	NULL
and	NULL
amounts	NULL
equivalent	NULL
to	NULL
the	NULL
mapped	NULL
RNA	NULL
were	NULL
analysed	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
mutant	NULL
BSAP	NULL
proteins	NULL
by	NULL
EMSA	NULL
with	NULL
a	NULL
labelled	NULL
CD19-2	NULL
(	NULL
A-ins	NULL
)	NULL
oligonucleotide	NULL
.	NULL

Only	NULL
the	NULL
relevant	NULL
part	NULL
of	NULL
the	NULL
autoradiograph	NULL
containing	NULL
the	NULL
protein-DNA	NULL
complexes	NULL
is	NULL
shown	NULL
.	NULL

(	NULL
B	NULL
)	NULL
N-terminal	NULL
deletion	NULL
analysis	NULL
of	NULL
the	NULL
transactivation	NULL
domain	NULL
.	NULL

The	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
internal	NULL
deletion	NULL
mutants	NULL
B10-B17	NULL
,	NULL
the	NULL
paired	NULL
domain	NULL
peptide	NULL
B18	NULL
and	NULL
wild-type	NULL
BSAP	NULL
(	NULL
B1	NULL
)	NULL
was	NULL
investigated	NULL
as	NULL
described	NULL
in	NULL
panel	NULL
A	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Immunofluorescence	NULL
analysis	NULL
.	NULL

Expression	NULL
plasmids	NULL
directing	NULL
the	NULL
synthesis	NULL
of	NULL
full-length	NULL
BSAP	NULL
(	NULL
B1	NULL
)	NULL
and	NULL
of	NULL
the	NULL
transcriptionally	NULL
inactive	NULL
mutant	NULL
B9	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
murine	NULL
COP-8	NULL
fibroblasts	NULL
,	NULL
and	NULL
the	NULL
transfected	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
a	NULL
polyclonal	NULL
rabbit	NULL
anti-BSAP	NULL
paired	NULL
domain	NULL
antiserum	NULL
(	NULL
Adams	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
which	NULL
was	NULL
detected	NULL
with	NULL
FITC-conjugated	NULL
goat	NULL
anti-rabbit	NULL
antibodies	NULL
.	NULL

Nuclei	NULL
were	NULL
visualized	NULL
by	NULL
DAPI	NULL
staining	NULL
of	NULL
chromosomal	NULL
DNA	NULL
.	NULL

transactivation	NULL
domain	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
the	NULL
use	NULL
of	NULL
an	NULL
artificial	NULL
reporter	NULL
construct	NULL
,	NULL
is	NULL
also	NULL
relevant	NULL
for	NULL
transcription	NULL
of	NULL
a	NULL
BSAP	NULL
target	NULL
gene	NULL
in	NULL
its	NULL
natural	NULL
chromatin	NULL
context	NULL
.	NULL

An	NULL
inhibitory	NULL
domain	NULL
at	NULL
the	NULL
extreme	NULL
C-terminus	NULL
downregulates	NULL
the	NULL
transactivation	NULL
function	NULL
of	NULL
BSAP	NULL
The	NULL
transactivation	NULL
function	NULL
of	NULL
BSAP	NULL
was	NULL
characterized	NULL
up	NULL
to	NULL
this	NULL
point	NULL
only	NULL
in	NULL
transiently	NULL
transfected	NULL
cells	NULL
of	NULL
the	NULL
plasma	NULL
cell	NULL
line	NULL
SP2/0	NULL
.	NULL

To	NULL
verify	NULL
the	NULL
conclusions	NULL
drawn	NULL
from	NULL
these	NULL
experiments	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
transactivation	NULL
potential	NULL
of	NULL
C-terminal	NULL
and	NULL
internal	NULL
BS	NULL
AP	NULL
deletion	NULL
mutants	NULL
in	NULL
another	NULL
murine	NULL
plasma	NULL
cell	NULL
line	NULL
,	NULL
J558L	NULL
.	NULL

A	NULL
representative	NULL
analysis	NULL
of	NULL
the	NULL
C-terminal	NULL
deletion	NULL
mutants	NULL
in	NULL
these	NULL
cells	NULL
is	NULL
shown	NULL
in	NULL
Figure	NULL
6	NULL
.	NULL

To	NULL
our	NULL
surprise	NULL
,	NULL
maximal	NULL
transcriptional	NULL
activity	NULL
of	NULL
BSAP	NULL
was	NULL
only	NULL
observed	NULL
if	NULL
22	NULL
amino	NULL
acids	NULL
were	NULL
deleted	NULL
from	NULL
the	NULL
C-terminus	NULL
in	NULL
the	NULL
mutant	NULL
protein	NULL
B3	NULL
.	NULL

Upon	NULL
further	NULL
deletion	NULL
of	NULL
sequences	NULL
,	NULL
the	NULL
transactivation	NULL
potential	NULL
was	NULL
decreased	NULL
in	NULL
mutant	NULL
B5	NULL
to	NULL
the	NULL
same	NULL
low	NULL
level	NULL
seen	NULL
with	NULL
the	NULL
full-length	NULL
protein	NULL
B1	NULL
.	NULL

This	NULL
basal	NULL
level	NULL
of	NULL
transactivation	NULL
was	NULL
,	NULL
however	NULL
,	NULL
1974	NULL
significantly	NULL
higher	NULL
than	NULL
the	NULL
background	NULL
level	NULL
of	NULL
B-globin	NULL
transcription	NULL
observed	NULL
with	NULL
the	NULL
empty	NULL
expression	NULL
vector	NULL
pKW2T	NULL
(	NULL
Figure	NULL
6	NULL
)	NULL
or	NULL
with	NULL
the	NULL
paired	NULL
domain	NULL
peptide	NULL
B18	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Several	NULL
tentative	NULL
conclusions	NULL
can	NULL
be	NULL
drawn	NULL
from	NULL
these	NULL
results	NULL
.	NULL

First	NULL
,	NULL
the	NULL
C-terminal	NULL
transactivation	NULL
domain	NULL
of	NULL
BSAP	NULL
is	NULL
immediately	NULL
flanked	NULL
by	NULL
inhibitory	NULL
sequences	NULL
which	NULL
are	NULL
located	NULL
at	NULL
the	NULL
extreme	NULL
C-terminus	NULL
and	NULL
which	NULL
appear	NULL
to	NULL
be	NULL
inactive	NULL
in	NULL
SP2/0	NULL
cells	NULL
.	NULL

Second	NULL
,	NULL
the	NULL
C-terminal	NULL
boundary	NULL
of	NULL
this	NULL
transactivation	NULL
domain	NULL
is	NULL
the	NULL
same	NULL
in	NULL
both	NULL
plasma	NULL
cell	NULL
lines	NULL
(	NULL
J558L	NULL
and	NULL
SP2/0	NULL
)	NULL
.	NULL

Third	NULL
,	NULL
a	NULL
weak	NULL
transactivation	NULL
function	NULL
resides	NULL
within	NULL
internal	NULL
BSAP	NULL
sequences	NULL
which	NULL
are	NULL
located	NULL
between	NULL
the	NULL
C-terminal	NULL
transactivation	NULL
region	NULL
and	NULL
the	NULL
N-terminal	NULL
paired	NULL
domain	NULL
.	NULL

Fourth	NULL
,	NULL
only	NULL
the	NULL
potent	NULL
C-terminal	NULL
transactivation	NULL
sequences	NULL
,	NULL
but	NULL
not	NULL
the	NULL
weakly	NULL
active	NULL
internal	NULL
sequences	NULL
,	NULL
appear	NULL
to	NULL
be	NULL
under	NULL
negative	NULL
control	NULL
by	NULL
the	NULL
inhibitory	NULL
domain	NULL
at	NULL
the	NULL
extreme	NULL
C-terminus	NULL
.	NULL

To	NULL
facilitate	NULL
quantitation	NULL
of	NULL
the	NULL
results	NULL
,	NULL
we	NULL
repeated	NULL
and	NULL
extended	NULL
the	NULL
above	NULL
transient	NULL
transfection	NULL
analysis	NULL
with	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
(	NULL
luc-CD19	NULL
;	NULL
Figure	NULL
7E	NULL
)	NULL
which	NULL
is	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
same	NULL
BSAP-dependent	NULL
promoter	NULL
SP2/0	NULL
plasma	NULL
cells	NULL
6	NULL
5	NULL
&	NULL
©	NULL
$	NULL
0	NULL
aS	NULL
9	NULL
3	NULL
_	NULL
]	NULL
a	NULL
q	NULL
o	NULL
B1	NULL
B4	NULL
B10	NULL
B16	NULL
B17	NULL
KWaT	NULL
BSAP	NULL
LUCIFERASE	NULL
3x	NULL
tk	NULL
promoter	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

The	NULL
minimal	NULL
transactivation	NULL
domain	NULL
of	NULL
BSAP	NULL
is	NULL
sufficient	NULL
to	NULL
activate	NULL
transcription	NULL
from	NULL
an	NULL
enhancer	NULL
position	NULL
.	NULL

The	NULL
luciferase	NULL
gene	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
schematically	NULL
depicted	NULL
below	NULL
and	NULL
expression	NULL
plasmids	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
for	NULL
wild-type	NULL
BSAP	NULL
(	NULL
B1	NULL
)	NULL
or	NULL
the	NULL
indicated	NULL
mutant	NULL
proteins	NULL
were	NULL
transiently	NULL
transfected	NULL
together	NULL
with	NULL
a	NULL
reference	NULL
CMV-CAT	NULL
gene	NULL
(	NULL
0.1	NULL
ug	NULL
)	NULL
into	NULL
SP2/0	NULL
cells	NULL
.	NULL

Luciferase	NULL
activities	NULL
were	NULL
standardized	NULL
relative	NULL
to	NULL
CAT	NULL
values	NULL
to	NULL
normalize	NULL
for	NULL
differences	NULL
in	NULL
transfection	NULL
efficiencies	NULL
.	NULL

For	NULL
each	NULL
construct	NULL
,	NULL
the	NULL
average	NULL
luciferase	NULL
value	NULL
of	NULL
four	NULL
independent	NULL
experiments	NULL
is	NULL
shown	NULL
relative	NULL
to	NULL
the	NULL
luciferase	NULL
activity	NULL
measured	NULL
with	NULL
the	NULL
empty	NULL
expression	NULL
vector	NULL
pKW2T	NULL
.	NULL

Error	NULL
bars	NULL
indicate	NULL
standard	NULL
deviations	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

The	NULL
luciferase	NULL
reporter	NULL
gene	NULL
used	NULL
was	NULL
previously	NULL
described	NULL
as	NULL
lucTK-GAL/CDI19	NULL
(	NULL
Czerny	NULL
and	NULL
Busslinger	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

as	NULL
the	NULL
glob-CD19	NULL
gene	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
the	NULL
experiment	NULL
shown	NULL
in	NULL
Figure	NULL
6	NULL
,	NULL
deletion	NULL
of	NULL
33	NULL
C-terminal	NULL
amino	NULL
acids	NULL
in	NULL
mutant	NULL
B4	NULL
consistently	NULL
led	NULL
to	NULL
a	NULL
4-fold	NULL
increase	NULL
of	NULL
the	NULL
transactivation	NULL
potential	NULL
compared	NULL
with	NULL
full-length	NULL
BSAP	NULL
(	NULL
B1	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
additional	NULL
deletion	NULL
of	NULL
internal	NULL
amino	NULL
acids	NULL
170-280	NULL
in	NULL
mutant	NULL
B16	NULL
did	NULL
not	NULL
lower	NULL
the	NULL
maximal	NULL
transcriptional	NULL
activity	NULL
of	NULL
BSAP	NULL
in	NULL
J558L	NULL
cells	NULL
(	NULL
Figure	NULL
7A	NULL
)	NULL
.	NULL

This	NULL
result	NULL
therefore	NULL
indicates	NULL
that	NULL
internal	NULL
sequences	NULL
do	NULL
not	NULL
significantly	NULL
contribute	NULL
to	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
BSAP	NULL
,	NULL
as	NULL
long	NULL
as	NULL
the	NULL
potent	NULL
C-terminal	NULL
transactivation	NULL
function	NULL
is	NULL
unmasked	NULL
by	NULL
deletion	NULL
of	NULL
sequences	NULL
from	NULL
the	NULL
extreme	NULL
C-terminus	NULL
.	NULL

However	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
same	NULL
internal	NULL
region	NULL
in	NULL
the	NULL
context	NULL
of	NULL
an	NULL
intact	NULL
C-terminus	NULL
resulted	NULL
in	NULL
a	NULL
7-fold	NULL
lower	NULL
activity	NULL
of	NULL
the	NULL
mutant	NULL
protein	NULL
B10	NULL
compared	NULL
with	NULL
full-length	NULL
BSAP	NULL
(	NULL
B1	NULL
;	NULL
Figure	NULL
7A	NULL
)	NULL
,	NULL
thus	NULL
corroborating	NULL
that	NULL
the	NULL
weak	NULL
transactivation	NULL
function	NULL
of	NULL
internal	NULL
sequences	NULL
(	NULL
amino	NULL
acids	NULL
170-280	NULL
)	NULL
is	NULL
not	NULL
repressed	NULL
by	NULL
the	NULL
C-terminal	NULL
inhibitory	NULL
domain	NULL
in	NULL
full-length	NULL
BSAP	NULL
(	NULL
B1	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
C-terminal	NULL
transactivation	NULL
function	NULL
is	NULL
under	NULL
tight	NULL
negative	NULL
regulation	NULL
by	NULL
the	NULL
adjacent	NULL
inhibitory	NULL
domain	NULL
as	NULL
evidenced	NULL
by	NULL
a	NULL
30-fold	NULL
difference	NULL
in	NULL
transactivation	NULL
potential	NULL
between	NULL
mutants	NULL
BIO	NULL
and	NULL
B16	NULL
,	NULL
both	NULL
of	NULL
which	NULL
lack	NULL
internal	NULL
sequences	NULL
(	NULL
Figure	NULL
7A	NULL
)	NULL
.	NULL

To	NULL
analyse	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
the	NULL
extreme	NULL
C-terminal	NULL
sequences	NULL
in	NULL
greater	NULL
detail	NULL
,	NULL
we	NULL
transfected	NULL
increasing	NULL
amounts	NULL
of	NULL
expression	NULL
plasmids	NULL
encoding	NULL
the	NULL
mutant	NULL
proteins	NULL
B1O	NULL
and	NULL
B16	NULL
into	NULL
J558L	NULL
cells	NULL
and	NULL
measured	NULL
the	NULL
transactivation	NULL
potential	NULL
as	NULL
well	NULL
as	NULL
protein	NULL
Transactivation	NULL
properties	NULL
of	NULL
BSAP	NULL
(	NULL
Pax-5	NULL
)	NULL
A	NULL
B	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

REH	NULL
cells	NULL
express	NULL
a	NULL
truncated	NULL
polypeptide	NULL
with	NULL
a	NULL
frameshift	NULL
mutation	NULL
eliminating	NULL
the	NULL
transactivation	NULL
function	NULL
of	NULL
BSAP	NULL
.	NULL

(	NULL
A	NULL
)	NULL
EMSA	NULL
analysis	NULL
.	NULL

Nuclear	NULL
extracts	NULL
of	NULL
the	NULL
human	NULL
B-lymphoid	NULL
cell	NULL
lines	NULL
REH	NULL
and	NULL
BJA-B	NULL
were	NULL
analysed	NULL
by	NULL
EMSA	NULL
in	NULL
parallel	NULL
with	NULL
whole	NULL
cell	NULL
extracts	NULL
of	NULL
COP-8	NULL
cells	NULL
that	NULL
were	NULL
transfected	NULL
with	NULL
expression	NULL
plasmids	NULL
containing	NULL
BSAP	NULL
cDNA	NULL
inserts	NULL
isolated	NULL
from	NULL
REH	NULL
cells	NULL
by	NULL
PCR	NULL
amplification	NULL
.	NULL

A	NULL
BSAP	NULL
recognition	NULL
sequence	NULL
originating	NULL
from	NULL
the	NULL
sea	NULL
urchin	NULL
H2A-2.2	NULL
gene	NULL
(	NULL
Barberis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
was	NULL
used	NULL
as	NULL
binding	NULL
probe	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
mutant	NULL
(	NULL
mut	NULL
)	NULL
and	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
BSAP	NULL
proteins	NULL
,	NULL
which	NULL
are	NULL
expressed	NULL
from	NULL
the	NULL
two	NULL
PAX-5	NULL
alleles	NULL
represented	NULL
by	NULL
cDNA	NULL
clones	NULL
1	NULL
and	NULL
2	NULL
,	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Transactivation	NULL
assay	NULL
.	NULL

The	NULL
transcriptional	NULL
activity	NULL
of	NULL
mutant	NULL
and	NULL
wild-type	NULL
BSAP	NULL
proteins	NULL
encoded	NULL
by	NULL
the	NULL
cDNA	NULL
clones	NULL
1	NULL
and	NULL
2	NULL
,	NULL
respectively	NULL
,	NULL
was	NULL
determined	NULL
by	NULL
transient	NULL
transfection	NULL
in	NULL
SP2/0	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
synthesis	NULL
of	NULL
the	NULL
BSAP	NULL
proteins	NULL
was	NULL
analysed	NULL
by	NULL
EMSA	NULL
exactly	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
of	NULL
Figure	NULL
3A	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Schematic	NULL
diagram	NULL
of	NULL
the	NULL
mutated	NULL
BSAP	NULL
polypeptide	NULL
.	NULL

The	NULL
insertion	NULL
of	NULL
a	NULL
single	NULL
C-residue	NULL
(	NULL
arrow	NULL
head	NULL
)	NULL
generates	NULL
a	NULL
truncated	NULL
protein	NULL
due	NULL
to	NULL
a	NULL
shift	NULL
in	NULL
reading	NULL
frame	NULL
(	NULL
wavy	NULL
line	NULL
)	NULL
.	NULL

This	NULL
mutation	NULL
affects	NULL
the	NULL
sequence	NULL
after	NULL
proline	NULL
321	NULL
of	NULL
BSAP	NULL
resulting	NULL
in	NULL
premature	NULL
termination	NULL
of	NULL
translation	NULL
after	NULL
the	NULL
18	NULL
amino	NULL
acid	NULL
residues	NULL
shown	NULL
.	NULL

expression	NULL
by	NULL
luciferase	NULL
and	NULL
EMSA	NULL
assays	NULL
,	NULL
respectively	NULL
(	NULL
Figure	NULL
7B	NULL
)	NULL
.	NULL

These	NULL
two	NULL
proteins	NULL
differ	NULL
from	NULL
each	NULL
other	NULL
only	NULL
by	NULL
the	NULL
presence	NULL
(	NULL
B10	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
B16	NULL
)	NULL
of	NULL
the	NULL
C-terminal	NULL
inhibitory	NULL
domain	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
7B	NULL
,	NULL
protein	NULL
B10	NULL
was	NULL
consistently	NULL
expressed	NULL
at	NULL
a	NULL
~4-fold	NULL
lower	NULL
level	NULL
than	NULL
protein	NULL
B16	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
last	NULL
33	NULL
amino	NULL
acids	NULL
of	NULL
BSAP	NULL
may	NULL
influence	NULL
protein	NULL
stability	NULL
in	NULL
J558L	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
comparison	NULL
of	NULL
the	NULL
transactivation	NULL
data	NULL
obtained	NULL
with	NULL
cells	NULL
expressing	NULL
similar	NULL
amounts	NULL
of	NULL
the	NULL
two	NULL
proteins	NULL
clearly	NULL
indicated	NULL
that	NULL
the	NULL
observed	NULL
discrepancies	NULL
are	NULL
not	NULL
caused	NULL
by	NULL
protein	NULL
instability	NULL
but	NULL
reflect	NULL
an	NULL
inherent	NULL
difference	NULL
in	NULL
the	NULL
transactivation	NULL
potential	NULL
of	NULL
the	NULL
two	NULL
proteins	NULL
(	NULL
compare	NULL
2	NULL
ug	NULL
of	NULL
B16	NULL
DNA	NULL
versus	NULL
8	NULL
ug	NULL
of	NULL
B10	NULL
DNA	NULL
;	NULL
Figure	NULL
7B	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
therefore	NULL
that	NULL
the	NULL
potent	NULL
C-terminal	NULL
transactivation	NULL
function	NULL
of	NULL
BSAP	NULL
is	NULL
tightly	NULL
regulated	NULL
in	NULL
J558L	NULL
cells	NULL
by	NULL
an	NULL
adjacent	NULL
inhibitory	NULL
domain	NULL
at	NULL
the	NULL
extreme	NULL
C-terminus	NULL
.	NULL

1975	NULL
P.Dorfler	NULL
and	NULL
M.Busslinger	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Negative	NULL
regulation	NULL
of	NULL
the	NULL
C-terminal	NULL
transactivation	NULL
function	NULL
of	NULL
BSAP	NULL
in	NULL
J558L	NULL
cells	NULL
.	NULL

Expression	NULL
plasmids	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
coding	NULL
for	NULL
full-length	NULL
BSAP	NULL
(	NULL
B1	NULL
)	NULL
or	NULL
the	NULL
C-terminal	NULL
deletion	NULL
mutants	NULL
B2-B7	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
cells	NULL
of	NULL
the	NULL
murine	NULL
plasma	NULL
cell	NULL
line	NULL
J558L	NULL
together	NULL
with	NULL
the	NULL
glob-CD19	NULL
(	NULL
7	NULL
ug	NULL
)	NULL
and	NULL
OVEC-ref	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
constructs	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
B-globin	NULL
mRNA	NULL
and	NULL
BSAP	NULL
protein	NULL
were	NULL
analysed	NULL
by	NULL
RNase	NULL
protection	NULL
assay	NULL
and	NULL
EMSA	NULL
,	NULL
respectively	NULL
(	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Figure	NULL
3A	NULL
)	NULL
.	NULL

Unspecific	NULL
protein-DNA	NULL
complexes	NULL
are	NULL
indicated	NULL
by	NULL
asterisks	NULL
.	NULL

The	NULL
C-terminal	NULL
transactivating	NULL
and	NULL
inhibitory	NULL
domains	NULL
of	NULL
BSAP	NULL
function	NULL
as	NULL
an	NULL
independent	NULL
module	NULL
in	NULL
B	NULL
cells	NULL
We	NULL
next	NULL
studied	NULL
the	NULL
function	NULL
of	NULL
the	NULL
C-terminal	NULL
region	NULL
of	NULL
BSAP	NULL
in	NULL
the	NULL
more	NULL
physiological	NULL
background	NULL
of	NULL
the	NULL
murine	NULL
B	NULL
cell	NULL
line	NULL
M12.4.1	NULL
,	NULL
which	NULL
expresses	NULL
endogenous	NULL
BSAP	NULL
.	NULL

To	NULL
be	NULL
able	NULL
to	NULL
distinguish	NULL
between	NULL
transactivation	NULL
by	NULL
endogenous	NULL
and	NULL
exogenous	NULL
BSAP	NULL
,	NULL
we	NULL
transferred	NULL
the	NULL
C-terminal	NULL
sequences	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
to	NULL
the	NULL
heterologous	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
the	NULL
yeast	NULL
GALA	NULL
protein	NULL
.	NULL

The	NULL
GAL4-BSAP	NULL
fusion	NULL
proteins	NULL
G1	NULL
,	NULL
G2	NULL
and	NULL
G3	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
were	NULL
transiently	NULL
expressed	NULL
in	NULL
M12.4.1	NULL
cells	NULL
,	NULL
and	NULL
their	NULL
transcriptional	NULL
activity	NULL
was	NULL
determined	NULL
,	NULL
using	NULL
a	NULL
co-transfected	NULL
GAL4-responsive	NULL
luciferase	NULL
gene	NULL
as	NULL
reporter	NULL
system	NULL
(	NULL
see	NULL
Figure	NULL
7E	NULL
)	NULL
.	NULL

As	NULL
illustrated	NULL
in	NULL
Figure	NULL
7C	NULL
,	NULL
the	NULL
chimeric	NULL
protein	NULL
G1	NULL
containing	NULL
both	NULL
the	NULL
transactivating	NULL
and	NULL
inhibitory	NULL
domains	NULL
of	NULL
BSAP	NULL
(	NULL
amino	NULL
acids	NULL
281-391	NULL
)	NULL
was	NULL
3-fold	NULL
less	NULL
active	NULL
than	NULL
protein	NULL
G2	NULL
(	NULL
amino	NULL
acids	NULL
281-358	NULL
)	NULL
lacking	NULL
the	NULL
inhibitory	NULL
region	NULL
at	NULL
its	NULL
C-terminus	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
mutant	NULL
G3	NULL
,	NULL
which	NULL
contained	NULL
only	NULL
the	NULL
minimal	NULL
transactivation	NULL
domain	NULL
(	NULL
amino	NULL
acids	NULL
319-358	NULL
)	NULL
as	NULL
defined	NULL
in	NULL
SP2/0	NULL
cells	NULL
,	NULL
was	NULL
almost	NULL
as	NULL
active	NULL
as	NULL
the	NULL
chimeric	NULL
protein	NULL
G2	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
protein	NULL
G2	NULL
increased	NULL
linearly	NULL
with	NULL
increasing	NULL
protein	NULL
amounts	NULL
(	NULL
Figure	NULL
7D	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
C-terminal	NULL
inhibitory	NULL
domain	NULL
repressed	NULL
the	NULL
transactivation	NULL
function	NULL
of	NULL
protein	NULL
G1	NULL
to	NULL
the	NULL
same	NULL
extent	NULL
even	NULL
at	NULL
high	NULL
protein	NULL
concentrations	NULL
(	NULL
Figure	NULL
7D	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
by	NULL
EMSA	NULL
analysis	NULL
,	NULL
the	NULL
observed	NULL
difference	NULL
in	NULL
transactivation	NULL
potential	NULL
did	NULL
not	NULL
result	NULL
from	NULL
altered	NULL
expression	NULL
of	NULL
the	NULL
mutant	NULL
proteins	NULL
G1	NULL
and	NULL
G2	NULL
in	NULL
M12.4.1	NULL
cells	NULL
(	NULL
Figure	NULL
7D	NULL
)	NULL
.	NULL

All	NULL
these	NULL
results	NULL
therefore	NULL
support	NULL
the	NULL
notion	NULL
that	NULL
the	NULL
inhibitory	NULL
domain	NULL
at	NULL
the	NULL
extreme	NULL
C-terminus	NULL
of	NULL
BSAP	NULL
is	NULL
also	NULL
active	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
that	NULL
the	NULL
entire	NULL
C-terminal	NULL
region	NULL
of	NULL
BSAP	NULL
functions	NULL
as	NULL
an	NULL
1976	NULL
independent	NULL
regulatory	NULL
module	NULL
in	NULL
the	NULL
context	NULL
of	NULL
an	NULL
unrelated	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

A	NULL
C-terminal	NULL
sequence	NULL
of	NULL
55	NULL
amino	NULL
acids	NULL
functions	NULL
as	NULL
a	NULL
cell	NULL
type-independent	NULL
transactivation	NULL
domain	NULL
of	NULL
BSAP	NULL
During	NULL
the	NULL
course	NULL
of	NULL
these	NULL
studies	NULL
we	NULL
realized	NULL
that	NULL
the	NULL
plasmacytoma	NULL
cell	NULL
line	NULL
SP2/0	NULL
was	NULL
atypical	NULL
in	NULL
two	NULL
respects	NULL
.	NULL

First	NULL
,	NULL
the	NULL
inhibitory	NULL
domain	NULL
of	NULL
BSAP	NULL
appeared	NULL
to	NULL
be	NULL
inactive	NULL
under	NULL
normal	NULL
growth	NULL
conditions	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Second	NULL
,	NULL
the	NULL
transactivation	NULL
potential	NULL
of	NULL
BSAP	NULL
was	NULL
highest	NULL
in	NULL
SP2/0	NULL
cells	NULL
compared	NULL
with	NULL
any	NULL
other	NULL
cell	NULL
line	NULL
tested	NULL
.	NULL

Both	NULL
properties	NULL
of	NULL
the	NULL
SP2/0	NULL
cells	NULL
greatly	NULL
facilitated	NULL
the	NULL
identification	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
C-terminal	NULL
transactivation	NULL
domain	NULL
of	NULL
BSAP	NULL
by	NULL
mutational	NULL
analysis	NULL
.	NULL

However	NULL
,	NULL
we	NULL
also	NULL
observed	NULL
that	NULL
the	NULL
minimal	NULL
transactivation	NULL
domain	NULL
(	NULL
amino	NULL
acids	NULL
319-358	NULL
)	NULL
as	NULL
defined	NULL
in	NULL
SP2/0	NULL
cells	NULL
did	NULL
not	NULL
possess	NULL
maximal	NULL
activity	NULL
in	NULL
J558L	NULL
,	NULL
RAC6S	NULL
and	NULL
M12.4.1	NULL
cells	NULL
(	NULL
construct	NULL
G3	NULL
in	NULL
Figure	NULL
7C	NULL
and	NULL
P.Dorfler	NULL
,	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
suggested	NULL
that	NULL
amino	NULL
acid	NULL
residues	NULL
between	NULL
positions	NULL
304	NULL
and	NULL
319	NULL
of	NULL
BSAP	NULL
which	NULL
are	NULL
highly	NULL
conserved	NULL
among	NULL
all	NULL
BSAP-related	NULL
Pax	NULL
proteins	NULL
(	NULL
Figure	NULL
9	NULL
)	NULL
may	NULL
also	NULL
be	NULL
required	NULL
for	NULL
full	NULL
activity	NULL
of	NULL
the	NULL
C-terminal	NULL
transactivation	NULL
domain	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hypothesis	NULL
,	NULL
we	NULL
analysed	NULL
the	NULL
activity	NULL
of	NULL
chimeric	NULL
GAL4-BSAP	NULL
proteins	NULL
containing	NULL
N-terminal	NULL
extensions	NULL
of	NULL
the	NULL
BSAP	NULL
transactivation	NULL
domain	NULL
in	NULL
transiently	NULL
transfected	NULL
cells	NULL
of	NULL
the	NULL
murine	NULL
embryonal	NULL
carcinoma	NULL
cell	NULL
line	NULL
RAC65	NULL
(	NULL
Pratt	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
8	NULL
,	NULL
the	NULL
fusion	NULL
protein	NULL
G4	NULL
with	NULL
an	NULL
N-terminal	NULL
extension	NULL
of	NULL
the	NULL
transactivation	NULL
domain	NULL
up	NULL
to	NULL
position	NULL
304	NULL
was	NULL
transcriptionally	NULL
as	NULL
active	NULL
as	NULL
protein	NULL
G2	NULL
(	NULL
281-358	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
protein	NULL
G3	NULL
comprising	NULL
just	NULL
the	NULL
minimal	NULL
transactivation	NULL
domain	NULL
(	NULL
319-358	NULL
)	NULL
was	NULL
reproducibly	NULL
lower	NULL
in	NULL
RAC6GS	NULL
cells	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
observations	NULL
in	NULL
other	NULL
cell	NULL
lines	NULL
.	NULL

Hence	NULL
,	NULL
only	NULL
an	NULL
extended	NULL
sequence	NULL
consisting	NULL
of	NULL
55	NULL
C-terminal	NULL
amino	NULL
acids	NULL
(	NULL
304-358	NULL
)	NULL
functions	NULL
as	NULL
a	NULL
potent	NULL
cell	NULL
type-independent	NULL
transactivation	NULL
domain	NULL
of	NULL
BSAP	NULL
.	NULL

The	NULL
C-terminal	NULL
regulatory	NULL
module	NULL
consisting	NULL
of	NULL
transactivating	NULL
and	NULL
inhibitory	NULL
sequences	NULL
is	NULL
functionally	NULL
conserved	NULL
in	NULL
all	NULL
BSAP-related	NULL
Pax	NULL
proteins	NULL
The	NULL
mammalian	NULL
BSAP	NULL
(	NULL
Pax-5	NULL
)	NULL
,	NULL
Pax-2	NULL
and	NULL
Pax-8	NULL
,	NULL
the	NULL
zebrafish	NULL
Pax-b	NULL
and	NULL
the	NULL
more	NULL
distantly	NULL
related	NULL
sea	NULL
urchin	NULL
Pax-258	NULL
constitute	NULL
a	NULL
subfamily	NULL
of	NULL
Pax	NULL
proteins	NULL
with	NULL
similar	NULL
structural	NULL
organization	NULL
.	NULL

All	NULL
of	NULL
these	NULL
proteins	NULL
are	NULL
highly	NULL
conserved	NULL
in	NULL
the	NULL
C-terminal	NULL
sequences	NULL
corresponding	NULL
to	NULL
the	NULL
transactivating	NULL
and	NULL
inhibitory	NULL
domains	NULL
of	NULL
BSAP	NULL
(	NULL
Figure	NULL
9	NULL
)	NULL
.	NULL

The	NULL
suPax-258	NULL
protein	NULL
is	NULL
the	NULL
only	NULL
notable	NULL
exception	NULL
as	NULL
it	NULL
shows	NULL
little	NULL
homology	NULL
with	NULL
the	NULL
inhibitory	NULL
sequences	NULL
of	NULL
BSAP	NULL
and	NULL
contains	NULL
a	NULL
132	NULL
amino	NULL
acid-long	NULL
extension	NULL
at	NULL
its	NULL
C-terminus	NULL
which	NULL
is	NULL
absent	NULL
in	NULL
the	NULL
other	NULL
Pax	NULL
proteins	NULL
(	NULL
T.Czerny	NULL
and	NULL
M.Busslinger	NULL
,	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Given	NULL
the	NULL
high	NULL
sequence	NULL
conservation	NULL
among	NULL
the	NULL
other	NULL
Pax	NULL
proteins	NULL
of	NULL
this	NULL
subfamily	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
possibility	NULL
that	NULL
sequence	NULL
homology	NULL
may	NULL
also	NULL
reflect	NULL
functional	NULL
conservation	NULL
of	NULL
the	NULL
transactivation	NULL
and	NULL
inhibitory	NULL
domains	NULL
.	NULL

We	NULL
linked	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
either	NULL
to	NULL
the	NULL
entire	NULL
C-terminal	NULL
sequence	NULL
of	NULL
each	NULL
of	NULL
the	NULL
Pax	NULL
proteins	NULL
shown	NULL
in	NULL
Figure	NULL
9	NULL
(	NULL
constructs	NULL
'+	NULL
inhibitory	NULL
domain	NULL
'	NULL
)	NULL
or	NULL
only	NULL
to	NULL
the	NULL
sequence	NULL
corresponding	NULL
to	NULL
the	NULL
transactivation	NULL
domain	NULL
of	NULL
BSAP	NULL
(	NULL
constructs	NULL
*-	NULL
inhibitory	NULL
Transactivation	NULL
properties	NULL
of	NULL
BSAP	NULL
(	NULL
Pax-5	NULL
)	NULL
J558L	NULL
plasma	NULL
cells	NULL
M12	NULL
B-cells	NULL
o	NULL
0	NULL
4	NULL
3	NULL
1	NULL
,	NULL
}	NULL
100	NULL
|	NULL
f	NULL
B1	NULL
B4	NULL
B16	NULL
B10	NULL
_	NULL
KW2T	NULL
-	NULL
G1	NULL
ev	NULL
G3	NULL
GAL	NULL
``	NULL
|	NULL
€	NULL
R	NULL
A	NULL
o	NULL
-K	NULL
as	NULL
a	NULL
&	NULL
S	NULL
G2	NULL
(	NULL
-	NULL
inh	NULL
.	NULL

dom	NULL
1	NULL
G1	NULL
(	NULL
+	NULL
inh	NULL
.	NULL

domain	NULL
3	NULL
B10	NULL
(	NULL
+	NULL
inh	NULL
.	NULL

doma	NULL
4	NULL
a	NULL
*s	NULL
be	NULL
-	NULL
-e	NULL
-	NULL
&	NULL
--	NULL
#	NULL
&	NULL
--	NULL
--	NULL
A	NULL
e__	NULL
o-0	NULL
2	NULL
4	NULL
6	NULL
8	NULL
-	NULL
ug	NULL
DNA	NULL
0	NULL
2	NULL
4	NULL
8	NULL
g	NULL
DNA	NULL
0.5	NULL
2	NULL
4	NULL
8	NULL
ug	NULL
DNA	NULL
0.5	NULL
2	NULL
8	NULL
g	NULL
DNA	NULL
t	NULL
~.Q	NULL
B16	NULL
whn	NULL
dis	NULL
-	NULL
G2	NULL
EMSA	NULL
EMSA	NULL
®	NULL
®	NULL
-500	NULL
wit	NULL
wite	NULL
-	NULL
C	NULL
;	NULL
--	NULL
>	NULL
(	NULL
§\\\	NULL
{	NULL
)	NULL
NR	NULL
--	NULL
|cuciremase	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

An	NULL
inhibitory	NULL
domain	NULL
at	NULL
the	NULL
extreme	NULL
C-terminus	NULL
downregulates	NULL
the	NULL
transactivation	NULL
function	NULL
of	NULL
BSAP	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Transactivation	NULL
potential	NULL
of	NULL
full-length	NULL
and	NULL
mutant	NULL
BSAP	NULL
proteins	NULL
in	NULL
J558L	NULL
plasma	NULL
cells	NULL
.	NULL

Expression	NULL
plasmids	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
directing	NULL
the	NULL
synthesis	NULL
of	NULL
wild-type	NULL
(	NULL
B1	NULL
)	NULL
or	NULL
mutant	NULL
(	NULL
B4	NULL
.	NULL

B10	NULL
.	NULL

B16	NULL
)	NULL
BSAP	NULL
proteins	NULL
were	NULL
electroporated	NULL
into	NULL
the	NULL
plasma	NULL
cell	NULL
line	NULL
J558L	NULL
together	NULL
with	NULL
the	NULL
luciferase	NULL
gene	NULL
luc-CD19	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
and	NULL
the	NULL
reference	NULL
CMV-CAT	NULL
gene	NULL
(	NULL
0.2	NULL
ug	NULL
)	NULL
.	NULL

Luciferase	NULL
activities	NULL
of	NULL
three	NULL
independent	NULL
transfection	NULL
experiments	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
measured	NULL
CAT	NULL
activities	NULL
and	NULL
are	NULL
shown	NULL
as	NULL
average	NULL
values	NULL
relative	NULL
to	NULL
the	NULL
activity	NULL
observed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
empty	NULL
expression	NULL
plasmid	NULL
pKW2T	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Concentration	NULL
dependence	NULL
of	NULL
transactivation	NULL
by	NULL
mutant	NULL
BSAP	NULL
proteins	NULL
.	NULL

Increasing	NULL
amounts	NULL
of	NULL
expression	NULL
vectors	NULL
coding	NULL
for	NULL
the	NULL
mutant	NULL
proteins	NULL
BIO	NULL
and	NULL
B16	NULL
were	NULL
transiently	NULL
transfected	NULL
together	NULL
with	NULL
the	NULL
luciferase	NULL
gene	NULL
luc-CD19	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
into	NULL
J558L	NULL
cells	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
expression	NULL
plasmid	NULL
was	NULL
equalized	NULL
by	NULL
addition	NULL
of	NULL
the	NULL
empty	NULL
expression	NULL
vector	NULL
pKW2T	NULL
.	NULL

Luciferase	NULL
activities	NULL
are	NULL
shown	NULL
relative	NULL
to	NULL
the	NULL
activity	NULL
measured	NULL
with	NULL
pKW2T	NULL
.	NULL

The	NULL
same	NULL
whole	NULL
cell	NULL
extracts	NULL
,	NULL
which	NULL
were	NULL
used	NULL
for	NULL
measuring	NULL
the	NULL
luciferase	NULL
activity	NULL
,	NULL
were	NULL
assayed	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
mutant	NULL
BSAP	NULL
proteins	NULL
by	NULL
EMSA	NULL
with	NULL
a	NULL
labelled	NULL
CD19-2	NULL
(	NULL
A-ins	NULL
)	NULL
oligonucleotide	NULL
.	NULL

Only	NULL
the	NULL
relevant	NULL
part	NULL
of	NULL
the	NULL
autoradiographs	NULL
containing	NULL
the	NULL
protein-DNA	NULL
complexes	NULL
is	NULL
shown	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Transactivation	NULL
by	NULL
chimeric	NULL
GAL4-BSAP	NULL
proteins	NULL
in	NULL
M12.4.1	NULL
B	NULL
cells	NULL
.	NULL

Expression	NULL
plasmids	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
encoding	NULL
the	NULL
chimeric	NULL
proteins	NULL
G1	NULL
,	NULL
G2	NULL
and	NULL
G3	NULL
or	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
GAL	NULL
)	NULL
of	NULL
the	NULL
yeast	NULL
GAL4	NULL
protein	NULL
were	NULL
electroporated	NULL
into	NULL
M12.4.1	NULL
B	NULL
cells	NULL
together	NULL
with	NULL
the	NULL
GAL4-responsive	NULL
reporter	NULL
gene	NULL
pIGC-lue	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
and	NULL
the	NULL
CMV-CAT	NULL
gene	NULL
(	NULL
0.1	NULL
ug	NULL
)	NULL
.	NULL

Normalized	NULL
luciferase	NULL
activities	NULL
of	NULL
six	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
as	NULL
average	NULL
values	NULL
relative	NULL
to	NULL
the	NULL
activity	NULL
measured	NULL
with	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
alone	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Concentration-dependent	NULL
transactivation	NULL
by	NULL
GAL4-BSAP	NULL
fusion	NULL
proteins	NULL
.	NULL

Increasing	NULL
amounts	NULL
of	NULL
the	NULL
G1	NULL
and	NULL
G2	NULL
expression	NULL
vectors	NULL
were	NULL
transfected	NULL
into	NULL
M12.4.1	NULL
B	NULL
cells	NULL
together	NULL
with	NULL
the	NULL
reporter	NULL
pIGC-luc	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
and	NULL
reference	NULL
CMV-CAT	NULL
genes	NULL
(	NULL
0.3	NULL
ug	NULL
)	NULL
.	NULL

Luciferase	NULL
activities	NULL
normalized	NULL
for	NULL
CAT	NULL
values	NULL
are	NULL
shown	NULL
relative	NULL
to	NULL
the	NULL
activity	NULL
measured	NULL
with	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
alone	NULL
.	NULL

The	NULL
chimeric	NULL
GAL4-BSAP	NULL
proteins	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
whole	NULL
cell	NULL
extracts	NULL
by	NULL
EMSA	NULL
with	NULL
a	NULL
labelled	NULL
GAL4	NULL
binding	NULL
site	NULL
.	NULL

(	NULL
E	NULL
)	NULL
Schematic	NULL
diagram	NULL
of	NULL
the	NULL
luciferase	NULL
reporter	NULL
genes	NULL
used	NULL
.	NULL

The	NULL
BSAP-dependent	NULL
reporter	NULL
construct	NULL
luc-CD19	NULL
(	NULL
shown	NULL
to	NULL
the	NULL
left	NULL
)	NULL
and	NULL
the	NULL
GAL4-responsive	NULL
reporter	NULL
gene	NULL
pIGC-luc	NULL
(	NULL
shown	NULL
to	NULL
the	NULL
right	NULL
)	NULL
were	NULL
previously	NULL
described	NULL
(	NULL
Czerny	NULL
and	NULL
Busslinger	NULL
.	NULL

1995	NULL
)	NULL
.	NULL

domain	NULL
'	NULL
;	NULL
Figure	NULL
10A	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
by	NULL
transient	NULL
transactivation	NULL
assay	NULL
of	NULL
these	NULL
chimeric	NULL
proteins	NULL
in	NULL
RAC65	NULL
cells	NULL
(	NULL
Figure	NULL
10A	NULL
)	NULL
,	NULL
all	NULL
fusion	NULL
proteins	NULL
containing	NULL
just	NULL
the	NULL
sequences	NULL
homologous	NULL
to	NULL
the	NULL
BSAP	NULL
transactivation	NULL
domain	NULL
activated	NULL
GAL4-dependent	NULL
luciferase	NULL
transcription	NULL
to	NULL
a	NULL
much	NULL
higher	NULL
level	NULL
than	NULL
those	NULL
proteins	NULL
which	NULL
in	NULL
addition	NULL
included	NULL
the	NULL
very	NULL
C-terminal	NULL
sequence	NULL
related	NULL
to	NULL
the	NULL
inhibitory	NULL
domain	NULL
of	NULL
BSAP	NULL
.	NULL

Moreover	NULL
,	NULL
EMSA	NULL
analysis	NULL
with	NULL
a	NULL
GAL4	NULL
binding	NULL
probe	NULL
did	NULL
not	NULL
reveal	NULL
significant	NULL
differences	NULL
in	NULL
protein	NULL
expression	NULL
levels	NULL
(	NULL
Figure	NULL
10A	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
these	NULL
data	NULL
demonstrate	NULL
that	NULL
the	NULL
regulatory	NULL
module	NULL
consisting	NULL
of	NULL
a	NULL
potent	NULL
transactivation	NULL
region	NULL
and	NULL
1977	NULL
P.	NULL
:	NULL
Dorfler	NULL
and	NULL
M.Busslinger	NULL
an	NULL
adjacent	NULL
inhibitory	NULL
domain	NULL
has	NULL
been	NULL
evolutionarily	NULL
conserved	NULL
among	NULL
all	NULL
members	NULL
of	NULL
the	NULL
BSAP	NULL
subfamily	NULL
of	NULL
Pax	NULL
proteins	NULL
.	NULL

The	NULL
extended	NULL
C-terminal	NULL
sequences	NULL
of	NULL
the	NULL
sea	NULL
urchin	NULL
A	NULL
6K	NULL
“	NULL
p15	NULL
Luciferase	NULL
activity	NULL
No	NULL
t	NULL
o	NULL
o	NULL
O	NULL
h	NULL
“	NULL
n	NULL
(	NULL
1	NULL
EMSA	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

Cell	NULL
type-independent	NULL
function	NULL
of	NULL
an	NULL
extended	NULL
BSAP	NULL
transactivation	NULL
domain	NULL
consisting	NULL
of	NULL
55	NULL
amino	NULL
acids	NULL
.	NULL

Expression	NULL
plasmids	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
encoding	NULL
the	NULL
indicated	NULL
GAL4-BSAP	NULL
fusion	NULL
proteins	NULL
or	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
GAL	NULL
)	NULL
were	NULL
transfected	NULL
into	NULL
the	NULL
murine	NULL
embryonal	NULL
carcinoma	NULL
cell	NULL
line	NULL
RAC6S	NULL
together	NULL
with	NULL
the	NULL
reporter	NULL
pIGC-luc	NULL
(	NULL
Sug	NULL
)	NULL
and	NULL
reference	NULL
CMV-CAT	NULL
(	NULL
0.3	NULL
ug	NULL
)	NULL
genes	NULL
.	NULL

Normalized	NULL
luciferase	NULL
activities	NULL
of	NULL
five	NULL
independent	NULL
transfection	NULL
experiments	NULL
are	NULL
shown	NULL
as	NULL
average	NULL
values	NULL
relative	NULL
to	NULL
the	NULL
activity	NULL
obtained	NULL
with	NULL
the	NULL
empty	NULL
expression	NULL
vector	NULL
pKW2T	NULL
.	NULL

The	NULL
same	NULL
whole	NULL
cell	NULL
extracts	NULL
which	NULL
were	NULL
used	NULL
for	NULL
measuring	NULL
luciferase	NULL
activity	NULL
were	NULL
also	NULL
assayed	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
GAL4	NULL
fusion	NULL
proteins	NULL
by	NULL
EMSA	NULL
with	NULL
a	NULL
GAL4	NULL
binding	NULL
site	NULL
probe	NULL
.	NULL

Asterisks	NULL
indicate	NULL
unspecific	NULL
protein-DNA	NULL
complexes	NULL
.	NULL

TRANSACTIVATION	NULL
DOMAIN	NULL
Pax-258	NULL
protein	NULL
were	NULL
also	NULL
capable	NULL
of	NULL
silencing	NULL
the	NULL
transactivation	NULL
function	NULL
,	NULL
although	NULL
they	NULL
share	NULL
little	NULL
homology	NULL
with	NULL
the	NULL
inhibitory	NULL
sequences	NULL
of	NULL
the	NULL
vertebrate	NULL
Pax-2	NULL
,	NULL
Pax-5	NULL
and	NULL
Pax-8	NULL
proteins	NULL
.	NULL

To	NULL
localize	NULL
further	NULL
the	NULL
inhibitory	NULL
domain	NULL
in	NULL
the	NULL
C-terminus	NULL
of	NULL
the	NULL
suPax-258	NULL
protein	NULL
,	NULL
we	NULL
introduced	NULL
a	NULL
stop	NULL
codon	NULL
into	NULL
the	NULL
GAL4-suPax-258	NULL
protein	NULL
after	NULL
amino	NULL
acid	NULL
position	NULL
427	NULL
,	NULL
which	NULL
corresponds	NULL
to	NULL
the	NULL
C-termini	NULL
of	NULL
the	NULL
other	NULL
Pax	NULL
proteins	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
10B	NULL
,	NULL
this	NULL
truncated	NULL
fusion	NULL
protein	NULL
(	NULL
338-427	NULL
)	NULL
was	NULL
still	NULL
able	NULL
to	NULL
fully	NULL
repress	NULL
the	NULL
transactivation	NULL
function	NULL
encoded	NULL
by	NULL
amino	NULL
acids	NULL
338	NULL
to	NULL
395	NULL
of	NULL
the	NULL
suPax-258	NULL
protein	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
inhibitory	NULL
domain	NULL
of	NULL
the	NULL
suPax-258	NULL
protein	NULL
was	NULL
also	NULL
mapped	NULL
next	NULL
to	NULL
the	NULL
transactivation	NULL
domain	NULL
in	NULL
analogy	NULL
to	NULL
the	NULL
other	NULL
BSAP-related	NULL
Pax	NULL
proteins	NULL
.	NULL

As	NULL
these	NULL
negative	NULL
regulatory	NULL
sequences	NULL
of	NULL
suPax-258	NULL
markedly	NULL
differ	NULL
from	NULL
the	NULL
corresponding	NULL
Pax-2	NULL
,	NULL
Pax-5	NULL
and	NULL
Pax-8	NULL
sequences	NULL
,	NULL
it	NULL
was	NULL
formally	NULL
possible	NULL
that	NULL
any	NULL
arbitrary	NULL
sequence	NULL
at	NULL
the	NULL
C-terminus	NULL
might	NULL
serve	NULL
the	NULL
purpose	NULL
of	NULL
inhibiting	NULL
the	NULL
adjacent	NULL
transactivation	NULL
domain	NULL
.	NULL

To	NULL
clarify	NULL
this	NULL
point	NULL
,	NULL
we	NULL
deleted	NULL
a	NULL
single	NULL
nucleotide	NULL
after	NULL
codon	NULL
358	NULL
in	NULL
the	NULL
BSAP	NULL
cDNA	NULL
sequence	NULL
which	NULL
shifted	NULL
the	NULL
reading	NULL
frame	NULL
immediately	NULL
downstream	NULL
of	NULL
the	NULL
transactivation	NULL
domain	NULL
,	NULL
thus	NULL
resulting	NULL
in	NULL
a	NULL
totally	NULL
unrelated	NULL
amino	NULL
acid	NULL
sequence	NULL
at	NULL
the	NULL
C-terminus	NULL
of	NULL
the	NULL
chimeric	NULL
protein	NULL
G6	NULL
(	NULL
Figures	NULL
2	NULL
and	NULL
9	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
10C	NULL
,	NULL
this	NULL
fusion	NULL
protein	NULL
was	NULL
transcriptionally	NULL
as	NULL
active	NULL
in	NULL
transfected	NULL
RAC6S	NULL
cells	NULL
as	NULL
protein	NULL
G4	NULL
lacking	NULL
the	NULL
inhibitory	NULL
domain	NULL
.	NULL

Hence	NULL
,	NULL
unique	NULL
C-terminal	NULL
sequences	NULL
of	NULL
the	NULL
BSAP-related	NULL
Pax	NULL
proteins	NULL
specify	NULL
an	NULL
inhibitory	NULL
function	NULL
which	NULL
has	NULL
been	NULL
conserved	NULL
together	NULL
with	NULL
the	NULL
adjacent	NULL
transactivation	NULL
domain	NULL
over	NULL
a	NULL
large	NULL
evolutionary	NULL
distance	NULL
.	NULL

Discussion	NULL
Our	NULL
analysis	NULL
of	NULL
the	NULL
transactivation	NULL
properties	NULL
of	NULL
BSAP	NULL
(	NULL
Pax-5	NULL
)	NULL
led	NULL
to	NULL
the	NULL
identification	NULL
of	NULL
a	NULL
C-terminal	NULL
protein	NULL
module	NULL
capable	NULL
of	NULL
tightly	NULL
controlling	NULL
the	NULL
activity	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
.	NULL

This	NULL
regulatory	NULL
region	NULL
consists	NULL
of	NULL
a	NULL
potent	NULL
cell	NULL
type-independent	NULL
transactivation	NULL
domain	NULL
of	NULL
55	NULL
INHIBITORY	NULL
DOMAIN	NULL
s	NULL
sw	NULL
Fig	NULL
.	NULL

9	NULL
.	NULL

Amino	NULL
acid	NULL
sequence	NULL
comparison	NULL
of	NULL
the	NULL
C-termini	NULL
of	NULL
BSAP-related	NULL
Pax	NULL
proteins	NULL
.	NULL

Amino	NULL
acid	NULL
sequences	NULL
constituting	NULL
the	NULL
transactivation	NULL
region	NULL
and	NULL
the	NULL
adjacent	NULL
inhibitory	NULL
domain	NULL
of	NULL
BSAP	NULL
(	NULL
hPax-5	NULL
)	NULL
(	NULL
Adams	NULL
er	NULL
a/	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
were	NULL
aligned	NULL
with	NULL
the	NULL
C-terminal	NULL
sequences	NULL
of	NULL
the	NULL
mouse	NULL
Pax-2	NULL
(	NULL
Dressler	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
mouse	NULL
Pax-8	NULL
(	NULL
Plachov	NULL
et	NULL
a/..	NULL
1990	NULL
)	NULL
,	NULL
zebrafish	NULL
Pax-b	NULL
(	NULL
Krauss	NULL
er	NULL
al..	NULL
1991	NULL
)	NULL
and	NULL
sea	NULL
urchin	NULL
Pax-258	NULL
proteins	NULL
.	NULL

The	NULL
paired	NULL
domain	NULL
of	NULL
the	NULL
Paracentrotus	NULL
lividus	NULL
Pax-258	NULL
protein	NULL
is	NULL
highly	NULL
homologous	NULL
to	NULL
that	NULL
of	NULL
the	NULL
vertebrate	NULL
Pax-2	NULL
,	NULL
Pax-5	NULL
and	NULL
Pax-8	NULL
proteins	NULL
,	NULL
indicating	NULL
that	NULL
Pax-258	NULL
is	NULL
a	NULL
sea	NULL
urchin	NULL
representative	NULL
of	NULL
this	NULL
Pax	NULL
protein	NULL
subfamily	NULL
(	NULL
T.Czerny	NULL
and	NULL
M.Busslinger	NULL
,	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Amino	NULL
acid	NULL
residues	NULL
that	NULL
are	NULL
identical	NULL
to	NULL
the	NULL
BSAP	NULL
sequence	NULL
are	NULL
highlighted	NULL
by	NULL
black	NULL
overlay	NULL
and	NULL
homologies	NULL
among	NULL
at	NULL
least	NULL
three	NULL
other	NULL
members	NULL
of	NULL
the	NULL
subfamily	NULL
are	NULL
indicated	NULL
by	NULL
grey	NULL
overlay	NULL
.	NULL

An	NULL
arrow	NULL
demarcates	NULL
the	NULL
experimentally	NULL
defined	NULL
boundary	NULL
separating	NULL
the	NULL
transactivation	NULL
region	NULL
and	NULL
inhibitory	NULL
domain	NULL
.	NULL

Filled	NULL
arrowheads	NULL
point	NULL
to	NULL
the	NULL
position	NULL
of	NULL
introns	NULL
in	NULL
the	NULL
PAX-2	NULL
,	NULL
PAX-5	NULL
and	NULL
PAX-8	NULL
genes	NULL
(	NULL
Kozmik	NULL
et	NULL
al..	NULL
1993	NULL
;	NULL
Sanyanusin	NULL
er	NULL
al..	NULL
1995	NULL
;	NULL
Z.Kozmik	NULL
and	NULL
M.Busslinger	NULL
,	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Numbers	NULL
refer	NULL
to	NULL
the	NULL
first	NULL
and	NULL
last	NULL
amino	NULL
acid	NULL
residues	NULL
of	NULL
each	NULL
Pax	NULL
protein	NULL
sequence	NULL
shown	NULL
.	NULL

The	NULL
deletion	NULL
end-points	NULL
of	NULL
the	NULL
different	NULL
BSAP	NULL
mutants	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
and	NULL
the	NULL
frameshift	NULL
mutation	NULL
identified	NULL
in	NULL
the	NULL
PAX-5	NULL
allele	NULL
of	NULL
REH	NULL
cells	NULL
(	NULL
Figure	NULL
5	NULL
)	NULL
are	NULL
shown	NULL
by	NULL
their	NULL
respective	NULL
amino	NULL
acid	NULL
positions	NULL
above	NULL
the	NULL
BSAP	NULL
sequence	NULL
.	NULL

Stop	NULL
codons	NULL
are	NULL
denoted	NULL
by	NULL
asterisks	NULL
and	NULL
gaps	NULL
introduced	NULL
for	NULL
optimal	NULL
sequence	NULL
alignment	NULL
by	NULL
dashed	NULL
lines	NULL
.	NULL

The	NULL
long	NULL
C-terminal	NULL
extension	NULL
of	NULL
the	NULL
suPax-258	NULL
protein	NULL
is	NULL
symbolized	NULL
by	NULL
dots	NULL
.	NULL

The	NULL
C-terminal	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
the	NULL
GAL4-BSAP	NULL
protein	NULL
G6	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
which	NULL
is	NULL
translated	NULL
in	NULL
an	NULL
alternate	NULL
reading	NULL
frame	NULL
downstream	NULL
of	NULL
the	NULL
transactivation	NULL
domain	NULL
due	NULL
to	NULL
a	NULL
frameshift	NULL
(	NULL
FS	NULL
)	NULL
mutation	NULL
is	NULL
shown	NULL
in	NULL
italics	NULL
.	NULL

1978	NULL
Transactivation	NULL
properties	NULL
of	NULL
BSAP	NULL
(	NULL
Pax-5	NULL
)	NULL
activity	NULL
Fig	NULL
.	NULL

10	NULL
.	NULL

The	NULL
C-terminal	NULL
module	NULL
consisting	NULL
of	NULL
activating	NULL
and	NULL
inhibitory	NULL
domains	NULL
is	NULL
functionally	NULL
conserved	NULL
in	NULL
all	NULL
BSAP-related	NULL
Pax	NULL
proteins	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Transactivation	NULL
by	NULL
GAL4-Pax	NULL
fusion	NULL
proteins	NULL
.	NULL

The	NULL
entire	NULL
C-terminal	NULL
sequences	NULL
of	NULL
each	NULL
of	NULL
the	NULL
Pax	NULL
proteins	NULL
shown	NULL
in	NULL
Figure	NULL
9	NULL
were	NULL
fused	NULL
to	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
GAL4	NULL
(	NULL
constructs	NULL
*+	NULL
inhibitory	NULL
domain	NULL
'	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
a	NULL
stop	NULL
codon	NULL
was	NULL
introduced	NULL
into	NULL
these	NULL
Pax	NULL
sequences	NULL
at	NULL
the	NULL
position	NULL
corresponding	NULL
to	NULL
the	NULL
C-terminal	NULL
boundary	NULL
of	NULL
the	NULL
BSAP	NULL
transactivation	NULL
domain	NULL
(	NULL
indicated	NULL
by	NULL
arrow	NULL
in	NULL
Figure	NULL
9	NULL
:	NULL
constructs	NULL
*-	NULL
inhibitory	NULL
domain	NULL
'	NULL
)	NULL
.	NULL

The	NULL
transactivating	NULL
potential	NULL
of	NULL
these	NULL
GAL4-Pax	NULL
fusion	NULL
proteins	NULL
was	NULL
analysed	NULL
in	NULL
transiently	NULL
transfected	NULL
RAC65	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
fusion	NULL
protein	NULL
was	NULL
detected	NULL
by	NULL
EMSA	NULL
in	NULL
whole	NULL
cell	NULL
extracts	NULL
exactly	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
of	NULL
Figure	NULL
8	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
different	NULL
GAL4-Pax	NULL
proteins	NULL
are	NULL
indicated	NULL
to	NULL
the	NULL
left	NULL
and	NULL
unspecific	NULL
protein-DNA	NULL
complexes	NULL
are	NULL
denoted	NULL
by	NULL
asterisks	NULL
to	NULL
the	NULL
right	NULL
.	NULL

The	NULL
GAL-suPax-258	NULL
protein	NULL
contained	NULL
the	NULL
extended	NULL
C-terminal	NULL
region	NULL
of	NULL
Pax-258	NULL
(	NULL
amino	NULL
acids	NULL
338-559	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Definition	NULL
of	NULL
the	NULL
inhibitory	NULL
domain	NULL
of	NULL
the	NULL
sea	NULL
urchin	NULL
Pax-258	NULL
protein	NULL
.	NULL

GAL4	NULL
fusion	NULL
proteins	NULL
containing	NULL
Pax-258	NULL
sequences	NULL
from	NULL
amino	NULL
acid	NULL
338	NULL
to	NULL
amino	NULL
acids	NULL
395	NULL
,	NULL
427	NULL
or	NULL
559.	NULL
respectively	NULL
,	NULL
were	NULL
expressed	NULL
in	NULL
transiently	NULL
transfected	NULL
RAC65	NULL
.	NULL

and	NULL
their	NULL
transactivation	NULL
potential	NULL
was	NULL
determined	NULL
as	NULL
described	NULL
in	NULL
Figure	NULL
8	NULL
.	NULL

Luciferase	NULL
activities	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
co-transfected	NULL
CMV-CAT	NULL
gene	NULL
and	NULL
are	NULL
shown	NULL
as	NULL
average	NULL
values	NULL
relative	NULL
to	NULL
the	NULL
activity	NULL
measured	NULL
with	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
GAL	NULL
)	NULL
alone	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Specific	NULL
sequence	NULL
requirement	NULL
of	NULL
the	NULL
inhibitory	NULL
domain	NULL
.	NULL

The	NULL
transcriptional	NULL
activities	NULL
of	NULL
the	NULL
GAL4-BSAP	NULL
fusion	NULL
proteins	NULL
G4	NULL
.	NULL

GS	NULL
and	NULL
G6	NULL
were	NULL
measured	NULL
.	NULL

and	NULL
the	NULL
data	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
were	NULL
evaluated	NULL
as	NULL
described	NULL
in	NULL
(	NULL
B	NULL
)	NULL
.	NULL

The	NULL
G6	NULL
protein	NULL
(	NULL
BSAP-FS	NULL
)	NULL
contained	NULL
an	NULL
unrelated	NULL
sequence	NULL
at	NULL
the	NULL
C-terminus	NULL
(	NULL
see	NULL
Figure	NULL
9	NULL
)	NULL
instead	NULL
of	NULL
the	NULL
inhibitory	NULL
domain	NULL
of	NULL
BSAP	NULL
.	NULL

amino	NULL
acids	NULL
and	NULL
of	NULL
adjacent	NULL
inhibitory	NULL
sequences	NULL
at	NULL
the	NULL
extreme	NULL
C-terminus	NULL
of	NULL
BSAP	NULL
.	NULL

The	NULL
same	NULL
modular	NULL
arrangement	NULL
of	NULL
positive	NULL
and	NULL
negative	NULL
regulatory	NULL
sequences	NULL
at	NULL
the	NULL
C-terminus	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
specific	NULL
feature	NULL
of	NULL
all	NULL
members	NULL
of	NULL
the	NULL
Pax	NULL
protein	NULL
subfamily	NULL
consisting	NULL
of	NULL
the	NULL
mammalian	NULL
BSAP	NULL
(	NULL
Pax-5	NULL
)	NULL
,	NULL
Pax-2	NULL
,	NULL
Pax-8	NULL
,	NULL
zebrafish	NULL
Pax-b	NULL
and	NULL
sea	NULL
urchin	NULL
Pax-258	NULL
proteins	NULL
.	NULL

The	NULL
C-terminal	NULL
regions	NULL
of	NULL
most	NULL
Pax	NULL
proteins	NULL
including	NULL
the	NULL
BSAP-related	NULL
transcription	NULL
factors	NULL
are	NULL
characterized	NULL
by	NULL
a	NULL
preponderance	NULL
of	NULL
serine	NULL
,	NULL
threonine	NULL
and	NULL
proline	NULL
residues	NULL
.	NULL

However	NULL
,	NULL
these	NULL
C-terminal	NULL
regions	NULL
vastly	NULL
differ	NULL
in	NULL
primary	NULL
sequence	NULL
between	NULL
members	NULL
of	NULL
individual	NULL
Pax	NULL
protein	NULL
subfamilies	NULL
(	NULL
Walther	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

To	NULL
date	NULL
,	NULL
potent	NULL
transactivation	NULL
functions	NULL
have	NULL
been	NULL
assigned	NULL
to	NULL
the	NULL
C-terminal	NULL
sequences	NULL
of	NULL
Pax-3	NULL
(	NULL
Chalepakis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
and	NULL
Pax-6	NULL
(	NULL
Glaser	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Czerny	NULL
and	NULL
Busslinger	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

It	NULL
appears	NULL
unlikely	NULL
that	NULL
the	NULL
transactivation	NULL
domains	NULL
of	NULL
these	NULL
two	NULL
Pax	NULL
proteins	NULL
are	NULL
also	NULL
flanked	NULL
by	NULL
negative	NULL
regulatory	NULL
sequences	NULL
analogous	NULL
to	NULL
those	NULL
of	NULL
the	NULL
BSAP-related	NULL
Pax	NULL
transcription	NULL
factors	NULL
.	NULL

First	NULL
,	NULL
the	NULL
C-terminal	NULL
143	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
mouse	NULL
Pax-6	NULL
protein	NULL
endow	NULL
a	NULL
chimeric	NULL
GAL4-mPax-6	NULL
fusion	NULL
protein	NULL
with	NULL
high	NULL
transcriptional	NULL
activity	NULL
in	NULL
J558L	NULL
cells	NULL
(	NULL
Czerny	NULL
and	NULL
Busslinger	NULL
,	NULL
1995	NULL
)	NULL
despite	NULL
the	NULL
fact	NULL
that	NULL
these	NULL
cells	NULL
show	NULL
maximal	NULL
silencing	NULL
of	NULL
the	NULL
transactivation	NULL
func-	NULL
tion	NULL
of	NULL
BSAP	NULL
.	NULL

Second	NULL
,	NULL
functional	NULL
analysis	NULL
has	NULL
recently	NULL
localized	NULL
a	NULL
potent	NULL
transactivation	NULL
domain	NULL
within	NULL
the	NULL
last	NULL
78	NULL
C-terminal	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
Pax-3	NULL
protein	NULL
,	NULL
while	NULL
an	NULL
inhibitory	NULL
activity	NULL
was	NULL
mapped	NULL
to	NULL
the	NULL
first	NULL
90	NULL
N-terminal	NULL
residues	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
(	NULL
Chalepakis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
C-terminal	NULL
regulatory	NULL
module	NULL
of	NULL
BSAP-related	NULL
Pax	NULL
proteins	NULL
is	NULL
highly	NULL
biased	NULL
in	NULL
its	NULL
amino	NULL
acid	NULL
composition	NULL
.	NULL

Its	NULL
88	NULL
amino	NULL
acid-long	NULL
sequence	NULL
contains	NULL
11	NULL
or	NULL
more	NULL
proline	NULL
residues	NULL
and	NULL
>	NULL
25	NULL
hydroxylated	NULL
amino	NULL
acids	NULL
(	NULL
serine	NULL
,	NULL
threonine	NULL
and	NULL
tyrosine	NULL
)	NULL
.	NULL

As	NULL
a	NULL
consequence	NULL
,	NULL
the	NULL
entire	NULL
domain	NULL
is	NULL
predicted	NULL
to	NULL
be	NULL
exposed	NULL
as	NULL
an	NULL
unstructured	NULL
and	NULL
hydrophilic	NULL
tail	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
these	NULL
Pax	NULL
proteins	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
the	NULL
entire	NULL
C-terminal	NULL
module	NULL
is	NULL
encoded	NULL
by	NULL
three	NULL
exons	NULL
with	NULL
conserved	NULL
intron	NULL
positions	NULL
in	NULL
the	NULL
PAX-2	NULL
(	NULL
Sanyanusin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
PAX-8	NULL
(	NULL
Kozmik	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
and	NULL
PAX-5	NULL
genes	NULL
(	NULL
Busslinger	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
see	NULL
Figure	NULL
9	NULL
)	NULL
.	NULL

The	NULL
first	NULL
and	NULL
last	NULL
of	NULL
these	NULL
exons	NULL
code	NULL
exclusively	NULL
for	NULL
transactivating	NULL
or	NULL
inhibitory	NULL
amino	NULL
acid	NULL
residues	NULL
,	NULL
respectively	NULL
,	NULL
while	NULL
the	NULL
second	NULL
exon	NULL
contributes	NULL
to	NULL
both	NULL
protein	NULL
domains	NULL
.	NULL

Amino	NULL
acid	NULL
358	NULL
of	NULL
BSAP	NULL
was	NULL
experimentally	NULL
determined	NULL
to	NULL
be	NULL
at	NULL
the	NULL
boundary	NULL
between	NULL
the	NULL
transactivating	NULL
and	NULL
inhibitory	NULL
sequences	NULL
(	NULL
see	NULL
Figure	NULL
9	NULL
)	NULL
.	NULL

It	NULL
is	NULL
,	NULL
however	NULL
,	NULL
conceivable	NULL
that	NULL
the	NULL
negative	NULL
regulatory	NULL
1979	NULL
P.Dorfler	NULL
and	NULL
M.Busslinger	NULL
domain	NULL
extends	NULL
N-terminally	NULL
up	NULL
to	NULL
the	NULL
next	NULL
exon-intron	NULL
boundary	NULL
(	NULL
amino	NULL
acid	NULL
338	NULL
)	NULL
and	NULL
may	NULL
thus	NULL
partially	NULL
overlap	NULL
with	NULL
the	NULL
transactivation	NULL
region	NULL
(	NULL
Figure	NULL
9	NULL
)	NULL
.	NULL

A	NULL
possible	NULL
N-terminal	NULL
extension	NULL
would	NULL
also	NULL
increase	NULL
the	NULL
homology	NULL
of	NULL
the	NULL
inhibitory	NULL
sequences	NULL
of	NULL
the	NULL
sea	NULL
urchin	NULL
Pax-258	NULL
protein	NULL
with	NULL
those	NULL
of	NULL
the	NULL
other	NULL
BSAP-related	NULL
Pax	NULL
proteins	NULL
.	NULL

In	NULL
support	NULL
of	NULL
such	NULL
an	NULL
idea	NULL
,	NULL
the	NULL
sequences	NULL
from	NULL
amino	NULL
acids	NULL
359	NULL
to	NULL
391	NULL
of	NULL
BSAP	NULL
failed	NULL
to	NULL
function	NULL
as	NULL
an	NULL
autonomous	NULL
inhibitory	NULL
domain	NULL
upon	NULL
transplantation	NULL
to	NULL
a	NULL
heterologous	NULL
protein	NULL
,	NULL
as	NULL
they	NULL
were	NULL
unable	NULL
to	NULL
silence	NULL
the	NULL
acidic	NULL
and	NULL
serine/threonine-rich	NULL
transactivation	NULL
domains	NULL
of	NULL
GALA-VP16	NULL
and	NULL
GAL4-TFE3	NULL
(	NULL
Seipel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
,	NULL
respectively	NULL
(	NULL
P.Dorfler	NULL
,	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
negative	NULL
regulatory	NULL
domain	NULL
could	NULL
act	NULL
in	NULL
a	NULL
sequence-specific	NULL
manner	NULL
to	NULL
suppress	NULL
only	NULL
the	NULL
transactivation	NULL
function	NULL
of	NULL
BSAP-related	NULL
Pax	NULL
proteins	NULL
in	NULL
analogy	NULL
to	NULL
a	NULL
recently	NULL
described	NULL
inhibitory	NULL
domain	NULL
of	NULL
c-Fos	NULL
which	NULL
is	NULL
able	NULL
to	NULL
inactivate	NULL
just	NULL
one	NULL
(	NULL
HOB1	NULL
)	NULL
of	NULL
several	NULL
transactivation	NULL
modules	NULL
(	NULL
Brown	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
few	NULL
target	NULL
genes	NULL
which	NULL
are	NULL
to	NULL
date	NULL
known	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
BSAP-related	NULL
Pax	NULL
proteins	NULL
indicate	NULL
that	NULL
critical	NULL
recognition	NULL
sequences	NULL
for	NULL
these	NULL
transcription	NULL
factors	NULL
are	NULL
found	NULL
in	NULL
various	NULL
positions	NULL
relative	NULL
to	NULL
the	NULL
site	NULL
of	NULL
transcription	NULL
-	NULL
initiation	NULL
.	NULL

Functional	NULL
binding	NULL
sites	NULL
for	NULL
Pax-5	NULL
(	NULL
BSAP	NULL
)	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
a	NULL
midbrain-specific	NULL
enhancer	NULL
of	NULL
the	NULL
Engrailed-2	NULL
gene	NULL
(	NULL
Song	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
and	NULL
in	NULL
the	NULL
downstream	NULL
3	NULL
'	NULL
o	NULL
enhancer	NULL
of	NULL
the	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
gene	NULL
locus	NULL
(	NULL
Singh	NULL
and	NULL
Birshtein	NULL
,	NULL
1993	NULL
;	NULL
Neurath	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
recognition	NULL
sequences	NULL
for	NULL
the	NULL
sea	NULL
urchin	NULL
Pax-258	NULL
and	NULL
mammalian	NULL
Pax-8	NULL
proteins	NULL
were	NULL
found	NULL
upstream	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
in	NULL
the	NULL
proximal	NULL
promoters	NULL
of	NULL
a	NULL
subset	NULL
of	NULL
sea	NULL
urchin	NULL
histone	NULL
genes	NULL
(	NULL
Barberis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
and	NULL
the	NULL
mammalian	NULL
thyro-peroxidase	NULL
gene	NULL
(	NULL
Zannini	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
our	NULL
transactivation	NULL
study	NULL
we	NULL
have	NULL
used	NULL
artificial	NULL
reporter	NULL
genes	NULL
containing	NULL
Pax	NULL
binding	NULL
sites	NULL
in	NULL
proximal	NULL
promoter	NULL
and	NULL
distal	NULL
enhancer	NULL
positions	NULL
,	NULL
thus	NULL
approximating	NULL
the	NULL
situation	NULL
described	NULL
for	NULL
the	NULL
above	NULL
target	NULL
genes	NULL
.	NULL

It	NULL
is	NULL
therefore	NULL
reasonable	NULL
to	NULL
assume	NULL
that	NULL
transcription	NULL
of	NULL
these	NULL
natural	NULL
target	NULL
genes	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
C-terminal	NULL
regulatory	NULL
module	NULL
of	NULL
the	NULL
respective	NULL
Pax	NULL
protein	NULL
similar	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
reporter	NULL
genes	NULL
analysed	NULL
.	NULL

The	NULL
situation	NULL
is	NULL
,	NULL
however	NULL
,	NULL
different	NULL
for	NULL
the	NULL
BSAP	NULL
target	NULL
genes	NULL
CDI9	NULL
and	NULL
Ig	NULL
coding	NULL
for	NULL
a	NULL
B	NULL
cell	NULL
surface	NULL
protein	NULL
and	NULL
the	NULL
germline	NULL
immunoglobulin	NULL
Cg	NULL
transcript	NULL
,	NULL
respectively	NULL
.	NULL

Both	NULL
of	NULL
these	NULL
genes	NULL
contain	NULL
a	NULL
high-affinity	NULL
BSAP	NULL
binding	NULL
site	NULL
instead	NULL
of	NULL
a	NULL
TATA	NULL
box	NULL
in	NULL
the	NULL
-30	NULL
region	NULL
upstream	NULL
of	NULL
a	NULL
cluster	NULL
of	NULL
heterogeneous	NULL
transcription	NULL
start	NULL
sites	NULL
(	NULL
Rothman	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Kozmik	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Hence	NULL
it	NULL
is	NULL
conceivable	NULL
that	NULL
BSAP	NULL
regulates	NULL
transcription	NULL
initiation	NULL
of	NULL
these	NULL
genes	NULL
through	NULL
direct	NULL
contact	NULL
with	NULL
the	NULL
basal	NULL
transcription	NULL
machinery	NULL
which	NULL
may	NULL
involve	NULL
BSAP	NULL
domains	NULL
other	NULL
than	NULL
the	NULL
C-terminal	NULL
regulatory	NULL
module	NULL
.	NULL

In	NULL
this	NULL
context	NULL
it	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
we	NULL
have	NULL
identified	NULL
a	NULL
frameshift	NULL
mutation	NULL
in	NULL
one	NULL
PAX-5	NULL
allele	NULL
of	NULL
the	NULL
human	NULL
ALL	NULL
cell	NULL
line	NULL
REH	NULL
which	NULL
shifts	NULL
the	NULL
reading	NULL
frame	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
minimal	NULL
transactivation	NULL
domain	NULL
of	NULL
BSAP	NULL
.	NULL

This	NULL
cell	NULL
line	NULL
therefore	NULL
expresses	NULL
a	NULL
putative	NULL
transdominant	NULL
protein	NULL
from	NULL
the	NULL
mutated	NULL
allele	NULL
and	NULL
only	NULL
half	NULL
of	NULL
the	NULL
normal	NULL
amount	NULL
of	NULL
transcriptionally	NULL
competent	NULL
BSAP	NULL
from	NULL
the	NULL
remaining	NULL
wild-type	NULL
allele	NULL
.	NULL

REH	NULL
cells	NULL
express	NULL
considerably	NULL
lower	NULL
CDI9	NULL
mRNA	NULL
levels	NULL
than	NULL
other	NULL
established	NULL
B-lymphoid	NULL
cell	NULL
lines	NULL
(	NULL
Kozmik	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
1980	NULL
we	NULL
have	NULL
recently	NULL
discovered	NULL
that	NULL
CDI9	NULL
expression	NULL
is	NULL
exquisitely	NULL
sensitive	NULL
to	NULL
the	NULL
dosage	NULL
of	NULL
BSAP	NULL
protein	NULL
in	NULL
cultured	NULL
murine	NULL
pro-B	NULL
cells	NULL
(	NULL
S.Nutt	NULL
and	NULL
M.Busslinger	NULL
,	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

The	NULL
lower	NULL
expression	NULL
level	NULL
of	NULL
the	NULL
endogenous	NULL
CDI9	NULL
gene	NULL
in	NULL
REH	NULL
cells	NULL
could	NULL
therefore	NULL
be	NULL
a	NULL
direct	NULL
consequence	NULL
of	NULL
truncating	NULL
the	NULL
BSAP	NULL
protein	NULL
by	NULL
frameshift	NULL
mutation	NULL
,	NULL
suggesting	NULL
that	NULL
intact	NULL
C-terminal	NULL
sequences	NULL
of	NULL
BSAP	NULL
are	NULL
also	NULL
required	NULL
for	NULL
efficient	NULL
transcription	NULL
of	NULL
the	NULL
TATA-less	NULL
CD19	NULL
gene	NULL
.	NULL

Silencing	NULL
of	NULL
a	NULL
transactivation	NULL
domain	NULL
by	NULL
inhibitory	NULL
sequences	NULL
has	NULL
been	NULL
described	NULL
for	NULL
several	NULL
other	NULL
transcription	NULL
factors	NULL
,	NULL
and	NULL
different	NULL
mechanisms	NULL
for	NULL
this	NULL
negative	NULL
regulation	NULL
have	NULL
been	NULL
proposed	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
the	NULL
c-Jun	NULL
protein	NULL
,	NULL
a	NULL
cell	NULL
type-specific	NULL
inhibitory	NULL
protein	NULL
was	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
negative	NULL
regulatory	NULL
sequences	NULL
(	NULL
8	NULL
and	NULL
&	NULL
domains	NULL
)	NULL
which	NULL
flank	NULL
and	NULL
thus	NULL
mask	NULL
the	NULL
N-terminal	NULL
transactivation	NULL
domain	NULL
al	NULL
(	NULL
Baichwal	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Like-wise	NULL
,	NULL
a	NULL
cellular	NULL
protein	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
silencing	NULL
the	NULL
transactivation	NULL
function	NULL
of	NULL
c-Fos	NULL
(	NULL
Brown	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
and	NULL
Spl	NULL
(	NULL
Murata	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
by	NULL
binding	NULL
to	NULL
inhibitory	NULL
sequences	NULL
located	NULL
adjacent	NULL
to	NULL
a	NULL
transactivation	NULL
domain	NULL
.	NULL

The	NULL
yeast	NULL
bHLH	NULL
protein	NULL
PHO4	NULL
represents	NULL
the	NULL
best	NULL
studied	NULL
case	NULL
of	NULL
a	NULL
transcription	NULL
factor	NULL
whose	NULL
transactivation	NULL
domain	NULL
is	NULL
masked	NULL
by	NULL
protein-protein	NULL
interaction	NULL
.	NULL

Inhibitory	NULL
sequences	NULL
present	NULL
on	NULL
either	NULL
side	NULL
of	NULL
the	NULL
transactivation	NULL
domain	NULL
of	NULL
PHO4	NULL
are	NULL
responsible	NULL
for	NULL
binding	NULL
of	NULL
the	NULL
cyclin-like	NULL
repressor	NULL
PHO8O	NULL
(	NULL
Jayaraman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

A	NULL
different	NULL
,	NULL
promoter-specific	NULL
repression	NULL
mechanism	NULL
has	NULL
been	NULL
postulated	NULL
for	NULL
the	NULL
transcription	NULL
factor	NULL
C/EBP	NULL
«	NULL
a	NULL
which	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
albumin	NULL
gene	NULL
.	NULL

The	NULL
function	NULL
of	NULL
an	NULL
inhibitory	NULL
domain	NULL
which	NULL
overlaps	NULL
with	NULL
one	NULL
of	NULL
three	NULL
transactivation	NULL
region	NULL
of	NULL
C/EBPa	NULL
was	NULL
alleviated	NULL
only	NULL
in	NULL
the	NULL
cooperative	NULL
environment	NULL
of	NULL
the	NULL
albumin	NULL
promoter	NULL
(	NULL
Nerlov	NULL
and	NULL
Ziff	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
transactivation	NULL
domains	NULL
of	NULL
C/EBPRB	NULL
(	NULL
NF-M	NULL
)	NULL
(	NULL
Kowenz-Leutz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
,	NULL
c-Myb	NULL
(	NULL
Dubendorff	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
and	NULL
the	NULL
mammalian	NULL
heat	NULL
shock	NULL
transcription	NULL
factor	NULL
1	NULL
(	NULL
Shi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Zuo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
appear	NULL
to	NULL
be	NULL
masked	NULL
from	NULL
contacting	NULL
the	NULL
transcription	NULL
machinery	NULL
by	NULL
intramolecular	NULL
interaction	NULL
of	NULL
inhibitory	NULL
and	NULL
transactivating	NULL
sequences	NULL
.	NULL

Whether	NULL
any	NULL
of	NULL
these	NULL
negative	NULL
regulatory	NULL
mechanisms	NULL
also	NULL
applies	NULL
to	NULL
the	NULL
BSAP-related	NULL
Pax	NULL
protein	NULL
,	NULL
remains	NULL
to	NULL
be	NULL
seen	NULL
.	NULL

It	NULL
is	NULL
,	NULL
however	NULL
,	NULL
worth	NULL
mentioning	NULL
that	NULL
BSAP	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
repression	NULL
of	NULL
the	NULL
3	NULL
'	NULL
a	NULL
enhancer	NULL
of	NULL
the	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
gene	NULL
locus	NULL
(	NULL
Singh	NULL
and	NULL
Birshtein	NULL
,	NULL
1993	NULL
;	NULL
Neurath	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
which	NULL
could	NULL
be	NULL
mediated	NULL
by	NULL
the	NULL
C-terminal	NULL
inhibitory	NULL
domain	NULL
of	NULL
BSAP	NULL
in	NULL
the	NULL
regulatory	NULL
context	NULL
of	NULL
this	NULL
enhancer	NULL
.	NULL

Negatively	NULL
regulated	NULL
transactivation	NULL
domains	NULL
appear	NULL
to	NULL
be	NULL
a	NULL
characteristic	NULL
feature	NULL
of	NULL
inducible	NULL
transcription	NULL
factors	NULL
which	NULL
are	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
intracellular	NULL
signalling	NULL
.	NULL

This	NULL
is	NULL
true	NULL
for	NULL
almost	NULL
all	NULL
of	NULL
the	NULL
transcriptional	NULL
regulators	NULL
discussed	NULL
above	NULL
.	NULL

One	NULL
of	NULL
the	NULL
best	NULL
studied	NULL
examples	NULL
is	NULL
the	NULL
transcription	NULL
factor	NULL
C/EBPB	NULL
(	NULL
NF-M	NULL
)	NULL
which	NULL
has	NULL
been	NULL
implicated	NULL
as	NULL
a	NULL
nuclear	NULL
target	NULL
for	NULL
cytokine-induced	NULL
gene	NULL
expression	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
(	NULL
Kowenz-Leutz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

C/EBPR	NULL
(	NULL
NF-M	NULL
)	NULL
contains	NULL
two	NULL
inhibitory	NULL
domains	NULL
(	NULL
CR5	NULL
and	NULL
CR7	NULL
)	NULL
which	NULL
interact	NULL
in	NULL
cis	NULL
with	NULL
the	NULL
transactivation	NULL
domain	NULL
and	NULL
thus	NULL
silence	NULL
its	NULL
function	NULL
.	NULL

A	NULL
highly	NULL
conserved	NULL
MAP	NULL
kinase	NULL
site	NULL
in	NULL
one	NULL
(	NULL
CR7	NULL
)	NULL
of	NULL
these	NULL
inhibitory	NULL
regions	NULL
is	NULL
directly	NULL
involved	NULL
in	NULL
the	NULL
negative	NULL
interaction	NULL
which	NULL
masks	NULL
the	NULL
transactivation	NULL
domain	NULL
.	NULL

Phosphorylation	NULL
of	NULL
this	NULL
site	NULL
in	NULL
response	NULL
to	NULL
activation	NULL
of	NULL
MAP	NULL
kinase	NULL
pathways	NULL
disrupts	NULL
this	NULL
intramolecular	NULL
interaction	NULL
and	NULL
thus	NULL
results	NULL
in	NULL
derepression	NULL
of	NULL
the	NULL
constitutive	NULL
transactivation	NULL
domain	NULL
of	NULL
C/EBPRB	NULL
(	NULL
NF-M	NULL
)	NULL
(	NULL
Kowenz-Leutz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
a	NULL
negatively	NULL
regulated	NULL
transactivation	NULL
domain	NULL
in	NULL
Pax-2	NULL
,	NULL
Pax-5	NULL
and	NULL
Pax-8	NULL
also	NULL
strongly	NULL
suggests	NULL
that	NULL
these	NULL
transcription	NULL
factors	NULL
are	NULL
at	NULL
the	NULL
receiving	NULL
end	NULL
of	NULL
signal	NULL
transduction	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

However	NULL
,	NULL
all	NULL
our	NULL
efforts	NULL
to	NULL
demonstrate	NULL
a	NULL
link	NULL
between	NULL
transcriptional	NULL
activation	NULL
of	NULL
BSAP	NULL
and	NULL
signal	NULL
transduction	NULL
have	NULL
so	NULL
far	NULL
failed	NULL
.	NULL

Stimulation	NULL
of	NULL
B	NULL
cell	NULL
lines	NULL
with	NULL
various	NULL
interleukins	NULL
,	NULL
serum	NULL
growth	NULL
factors	NULL
or	NULL
phorbol	NULL
esters	NULL
did	NULL
not	NULL
inactivate	NULL
the	NULL
silencing	NULL
function	NULL
of	NULL
the	NULL
C-terminal	NULL
inhibitory	NULL
domain	NULL
(	NULL
P.Dorfler	NULL
,	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Thus	NULL
it	NULL
will	NULL
be	NULL
a	NULL
challenge	NULL
for	NULL
the	NULL
future	NULL
to	NULL
identify	NULL
the	NULL
appropriate	NULL
signals	NULL
and	NULL
the	NULL
molecular	NULL
mechanisms	NULL
through	NULL
which	NULL
BSAP	NULL
and	NULL
its	NULL
related	NULL
transcription	NULL
factors	NULL
are	NULL
relieved	NULL
from	NULL
negative	NULL
regulation	NULL
by	NULL
their	NULL
C-terminal	NULL
inhibitory	NULL
domain	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Cell	NULL
lines	NULL
The	NULL
murine	NULL
B	NULL
cells	NULL
line	NULL
M12.4.1	NULL
(	NULL
Glimcher	NULL
et	NULL
a/..	NULL
1982	NULL
)	NULL
and	NULL
the	NULL
human	NULL
B-lymphoid	NULL
cell	NULL
lines	NULL
REH	NULL
(	NULL
Rosenfeld	NULL
er	NULL
a/..	NULL
1977	NULL
)	NULL
and	NULL
BJA-B	NULL
(	NULL
Barberis	NULL
et	NULL
al..	NULL
1990	NULL
)	NULL
all	NULL
express	NULL
endogenous	NULL
BSAP	NULL
.	NULL

In	NULL
contrast	NULL
.	NULL

the	NULL
murine	NULL
plasmacytoma	NULL
cell	NULL
lines	NULL
SP2/0	NULL
and	NULL
J5S58L	NULL
(	NULL
Barberis	NULL
et	NULL
«	NULL
/..	NULL
1990	NULL
)	NULL
.	NULL

the	NULL
embryonal	NULL
carcinoma	NULL
cell	NULL
line	NULL
RACKS	NULL
(	NULL
Pratt	NULL
er	NULL
a/..	NULL
1990	NULL
)	NULL
and	NULL
the	NULL
murine	NULL
fibroblast	NULL
cell	NULL
line	NULL
COP-8	NULL
(	NULL
Tyndall	NULL
et	NULL
a/..	NULL
1981	NULL
)	NULL
do	NULL
not	NULL
express	NULL
any	NULL
endogenous	NULL
BSAP	NULL
.	NULL

The	NULL
cell	NULL
lines	NULL
SP2/0	NULL
.	NULL

J558L	NULL
.	NULL

RACGS	NULL
and	NULL
COP-8	NULL
were	NULL
grown	NULL
in	NULL
high	NULL
glucose	NULL
DMEM	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
while	NULL
M12.4.1	NULL
.	NULL

BJA-B	NULL
and	NULL
REH	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

Plasmid	NULL
constructions	NULL
The	NULL
reporter	NULL
constructs	NULL
glob-CDI9	NULL
and	NULL
glob-CD19mut	NULL
were	NULL
created	NULL
by	NULL
cloning	NULL
three	NULL
copies	NULL
of	NULL
either	NULL
the	NULL
high-affinity	NULL
BSAP	NULL
binding	NULL
site	NULL
CDI19-2	NULL
(	NULL
A-ins	NULL
)	NULL
(	NULL
Czerny	NULL
er	NULL
al..	NULL
1993	NULL
)	NULL
or	NULL
a	NULL
mutated	NULL
site	NULL
(	NULL
oligonucleotides	NULL
1/2	NULL
;	NULL
lacking	NULL
the	NULL
A-insertion	NULL
and	NULL
containing	NULL
the	NULL
G	NULL
to	NULL
T	NULL
mutation	NULL
underlined	NULL
)	NULL
into	NULL
the	NULL
Sa/l	NULL
site	NULL
of	NULL
OVEC-S	NULL
(	NULL
Westin	NULL
er	NULL
al..	NULL
1987	NULL
)	NULL
.	NULL

The	NULL
SV40	NULL
enhancer	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
£coR	NULL
!	NULL

site	NULL
downstream	NULL
of	NULL
the	NULL
-globin	NULL
gene	NULL
.	NULL

The	NULL
eukaryotic	NULL
expression	NULL
vector	NULL
pKW2T	NULL
is	NULL
derived	NULL
from	NULL
pRK7	NULL
(	NULL
R.Kiein	NULL
and	NULL
D.Goeddel	NULL
.	NULL

unpublished	NULL
)	NULL
by	NULL
the	NULL
same	NULL
modifications	NULL
described	NULL
for	NULL
the	NULL
construction	NULL
of	NULL
pKWIO	NULL
(	NULL
Adams	NULL
et	NULL
a/..	NULL
1992	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
.	NULL

the	NULL
double-stranded	NULL
oligonucleotide	NULL
3/4	NULL
containing	NULL
stop	NULL
codons	NULL
in	NULL
all	NULL
reading	NULL
frames	NULL
was	NULL
inserted	NULL
downstream	NULL
of	NULL
the	NULL
polylinker	NULL
into	NULL
the	NULL
EcoRl	NULL
and	NULL
Clal	NULL
sites	NULL
.	NULL

The	NULL
BSAP	NULL
expression	NULL
plasmids	NULL
B1	NULL
.	NULL

B2	NULL
.	NULL

B4	NULL
.	NULL

B6	NULL
.	NULL

B8	NULL
.	NULL

B9	NULL
and	NULL
B18	NULL
were	NULL
generated	NULL
by	NULL
cloning	NULL
C-terminally	NULL
resected	NULL
BSAP	NULL
cDNAs	NULL
(	NULL
by	NULL
exonuclease	NULL
III	NULL
digestion	NULL
:	NULL
Adams	NULL
et	NULL
a/..	NULL
1992	NULL
)	NULL
into	NULL
the	NULL
HindIII	NULL
and	NULL
EcoRI	NULL
sites	NULL
of	NULL
pKW2T	NULL
.	NULL

Additional	NULL
C-terminal	NULL
truncations	NULL
of	NULL
BSAP	NULL
cDNA	NULL
were	NULL
created	NULL
by	NULL
PCR	NULL
using	NULL
oligonucleotide	NULL
5	NULL
as	NULL
common	NULL
5	NULL
!	NULL

primer	NULL
and	NULL
oligonucleotides	NULL
6	NULL
(	NULL
B3	NULL
)	NULL
.	NULL

7	NULL
(	NULL
B5	NULL
)	NULL
or	NULL
8	NULL
(	NULL
B7	NULL
)	NULL
as	NULL
3	NULL
'	NULL
primers	NULL
.	NULL

respectively	NULL
.	NULL

followed	NULL
by	NULL
cloning	NULL
of	NULL
the	NULL
Be/II-HindlIl	NULL
cDNA	NULL
fragments	NULL
into	NULL
the	NULL
BamHI	NULL
and	NULL
HindIII	NULL
sites	NULL
of	NULL
pKW10	NULL
(	NULL
Adams	NULL
et	NULL
a/..	NULL
1992	NULL
)	NULL
.	NULL

For	NULL
plasmids	NULL
BI0O-B17	NULL
.	NULL

PCR	NULL
fragments	NULL
with	NULL
EcoRI	NULL
ends	NULL
were	NULL
generated	NULL
and	NULL
inserted	NULL
into	NULL
the	NULL
EcoRI	NULL
site	NULL
downstream	NULL
of	NULL
the	NULL
paired	NULL
domain	NULL
of	NULL
clone	NULL
B18	NULL
(	NULL
except	NULL
for	NULL
clone	NULL
B13	NULL
.	NULL

where	NULL
the	NULL
cDNA	NULL
fragment	NULL
was	NULL
obtained	NULL
by	NULL
N-terminal	NULL
exonuclease	NULL
III	NULL
digestion	NULL
)	NULL
.	NULL

The	NULL
following	NULL
primer	NULL
pairs	NULL
were	NULL
used	NULL
for	NULL
generating	NULL
these	NULL
BSAP	NULL
cDNA	NULL
inserts	NULL
:	NULL
9/10	NULL
(	NULL
B10	NULL
)	NULL
:	NULL
11/15	NULL
(	NULL
Bll	NULL
12/15	NULL
(	NULL
B12	NULL
)	NULL
13715	NULL
(	NULL
Bid	NULL
)	NULL
:	NULL
14/15	NULL
(	NULL
B15	NULL
)	NULL
using	NULL
full-length	NULL
BSAP	NULL
cDNA	NULL
as	NULL
template	NULL
and	NULL
9/16	NULL
(	NULL
B16	NULL
)	NULL
and	NULL
12/16	NULL
(	NULL
B17	NULL
)	NULL
using	NULL
B4	NULL
cDNA	NULL
as	NULL
template	NULL
.	NULL

The	NULL
expression	NULL
plasmid	NULL
pKW-GAL-147	NULL
(	NULL
referred	NULL
to	NULL
as	NULL
GAL	NULL
in	NULL
Figure	NULL
2	NULL
)	NULL
was	NULL
constructed	NULL
by	NULL
cloning	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
amino	NULL
acids	NULL
1-147	NULL
)	NULL
of	NULL
GAL4	NULL
as	NULL
a	NULL
460	NULL
bp	NULL
Hindlll-C/al	NULL
fragment	NULL
from	NULL
pGal4-147	NULL
(	NULL
Bergers	NULL
er	NULL
al..	NULL
1995	NULL
)	NULL
into	NULL
the	NULL
HindIII	NULL
and	NULL
EcoRI	NULL
sites	NULL
of	NULL
pKW2T	NULL
.	NULL

Ligation	NULL
of	NULL
the	NULL
blunt-ended	NULL
C/al	NULL
and	NULL
EcoRI	NULL
sites	NULL
restored	NULL
the	NULL
downstream	NULL
EcoRI	NULL
site	NULL
used	NULL
for	NULL
insertion	NULL
of	NULL
Pax	NULL
cDNA	NULL
fragments	NULL
.	NULL

The	NULL
GAL4-BSAP	NULL
fusions	NULL
G1	NULL
.	NULL

G2	NULL
.	NULL

G3	NULL
.	NULL

GS	NULL
and	NULL
G4	NULL
were	NULL
generated	NULL
by	NULL
inserting	NULL
the	NULL
same	NULL
PCR	NULL
fragments	NULL
used	NULL
for	NULL
constructing	NULL
B10	NULL
.	NULL

B16	NULL
,	NULL
B17	NULL
.	NULL

B11	NULL
and	NULL
the	NULL
additional	NULL
EcoRI	NULL
PCR	NULL
fragment	NULL
generated	NULL
with	NULL
primers	NULL
11/16	NULL
on	NULL
template	NULL
B4	NULL
into	NULL
the	NULL
EcoRI	NULL
site	NULL
of	NULL
pKW-GAL-147	NULL
.	NULL

Analogous	NULL
GAL4	NULL
fusion	NULL
constructs	NULL
were	NULL
generated	NULL
with	NULL
PCR	NULL
fragments	NULL
obtained	NULL
from	NULL
mPax-2a	NULL
Transactivation	NULL
properties	NULL
of	NULL
BSAP	NULL
(	NULL
Pax-5	NULL
)	NULL
cDNA	NULL
(	NULL
Kozmik	NULL
et	NULL
a/..	NULL
1993	NULL
)	NULL
with	NULL
primers	NULL
17/18	NULL
(	NULL
long	NULL
insert	NULL
)	NULL
and	NULL
17/	NULL
19	NULL
(	NULL
short	NULL
insert	NULL
)	NULL
.	NULL

from	NULL
mPax-8a	NULL
cDNA	NULL
(	NULL
Kozmik	NULL
et	NULL
a/..	NULL
1993	NULL
)	NULL
with	NULL
primers	NULL
20/21	NULL
(	NULL
long	NULL
)	NULL
and	NULL
20/22	NULL
(	NULL
short	NULL
)	NULL
.	NULL

from	NULL
zfPax-b	NULL
cDNA	NULL
(	NULL
Krauss	NULL
et	NULL
al..	NULL
1991	NULL
)	NULL
with	NULL
primers	NULL
23/24	NULL
(	NULL
long	NULL
)	NULL
and	NULL
23/25	NULL
(	NULL
short	NULL
)	NULL
.	NULL

and	NULL
from	NULL
suPax-258	NULL
cDNA	NULL
with	NULL
primers	NULL
26/27	NULL
(	NULL
long	NULL
)	NULL
.	NULL

26/28	NULL
(	NULL
short	NULL
)	NULL
and	NULL
29/30	NULL
{	NULL
middle	NULL
:	NULL
cloned	NULL
as	NULL
C/al-BamHI	NULL
PCR	NULL
fragment	NULL
into	NULL
the	NULL
C/al	NULL
and	NULL
BamHI	NULL
sites	NULL
of	NULL
pGald-	NULL
147	NULL
)	NULL
.	NULL

The	NULL
BSAP	NULL
cDNA	NULL
part	NULL
of	NULL
the	NULL
GAL4-BSAP	NULL
frameshift	NULL
mutant	NULL
G6	NULL
was	NULL
assembled	NULL
by	NULL
ligating	NULL
two	NULL
EcoRI-Xbal	NULL
fragments	NULL
.	NULL

obtained	NULL
by	NULL
PCR	NULL
amplification	NULL
with	NULL
primers	NULL
11/31	NULL
and	NULL
32/33	NULL
.	NULL

into	NULL
the	NULL
EcoRI	NULL
site	NULL
of	NULL
pKW-GAL-147	NULL
.	NULL

PCR	NULL
cloning	NULL
of	NULL
mutated	NULL
BSAP	NULL
from	NULL
REH	NULL
cDNA	NULL
Poly	NULL
(	NULL
A	NULL
)	NULL
``	NULL
RNA	NULL
(	NULL
4	NULL
ug	NULL
)	NULL
from	NULL
the	NULL
cell	NULL
line	NULL
REH	NULL
(	NULL
Rosenfeld	NULL
et	NULL
al..	NULL
1977	NULL
)	NULL
was	NULL
reverse-transcribed	NULL
into	NULL
cDNA	NULL
by	NULL
priming	NULL
with	NULL
p	NULL
(	NULL
dT	NULL
)	NULL
;	NULL
s.	NULL
and	NULL
BSAP	NULL
encoding	NULL
sequences	NULL
were	NULL
isolated	NULL
by	NULL
PCR	NULL
amplification	NULL
with	NULL
primers	NULL
5/34	NULL
as	NULL
described	NULL
(	NULL
Adams	NULL
et	NULL
al..	NULL
1992	NULL
)	NULL
.	NULL

The	NULL
amplified	NULL
fragments	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
HindIII	NULL
and	NULL
BamHI	NULL
sites	NULL
of	NULL
the	NULL
pKW10	NULL
expression	NULL
vector	NULL
(	NULL
Adams	NULL
et	NULL
al..	NULL
1992	NULL
)	NULL
.	NULL

The	NULL
cDNA	NULL
inserts	NULL
of	NULL
selected	NULL
clones	NULL
coding	NULL
for	NULL
truncated	NULL
or	NULL
full-length	NULL
BSAP	NULL
were	NULL
analysed	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

Oligonucleotides	NULL
The	NULL
following	NULL
oligonucleotides	NULL
were	NULL
used	NULL
in	NULL
this	NULL
study	NULL
:	NULL
1	NULL
,	NULL
5-TCGACCT-GGAGAATGGGGCCTGAGGCGTIACCACCGCCTTCCTCTCTGG-	NULL
2	NULL
.	NULL

5-TCGACCAGAGAGGAAGGCGGTGGTAACGCCTCAGGC-CCCATTCTCCAGG-3	NULL
:	NULL
3	NULL
.	NULL

5-AATTCTAATTAACTAGAT-3	NULL
'	NULL
:	NULL
4	NULL
,	NULL
5'-CGATCTAGTTAATTAG-3	NULL
'	NULL
:	NULL
5	NULL
.	NULL

5-GCGAGATCTCCATTTCATCAA-GTCCTGAAA-3	NULL
'	NULL
:	NULL
6	NULL
,	NULL
5-GAGAGAAGCTIGCGGCCGCTAGGGGG-AGCCAAGCAGCCCCG-3	NULL
'	NULL
:	NULL
7	NULL
.	NULL

5-GAGAGAAGCTTGCGGCCGCTA-GGGACTCCCGGAAAACTCA-3	NULL
``	NULL
:	NULL
8	NULL
.	NULL

5-GAGAGAAGCTTIGCGGC-CGCTAGGGGACGTGTGGAGGGTACCCG-3	NULL
'	NULL
:	NULL
9	NULL
.	NULL

5-GGCGAATTC-CCCCACCCCTGCTGACATCGGG-3	NULL
'	NULL
;	NULL
10	NULL
.	NULL

5-GCGGAATICGGTGC-CATCAGTGTTTGGTGCC-3	NULL
'	NULL
:	NULL
11	NULL
.	NULL

5-GGCGAATTCCGGCCGTGAC-TTGGCGAGCACG-3	NULL
``	NULL
:	NULL
12	NULL
.	NULL

5-GGCGAATTCCGTCCCCCCCGCTGCG-ACAGGG-3	NULL
'	NULL
:	NULL
13	NULL
.	NULL

5-GGCGAATTCCCCCTACAGCCACCCTCAGTAT-3	NULL
'	NULL
14	NULL
.	NULL

5-GGCGAATTCCTGGAGGTTCCCCAACCCG-3	NULL
'	NULL
15	NULL
.	NULL

5'-GCGGAATTCGGTGCCATCAGTGTTTGGTGCC-3	NULL
'	NULL
:	NULL
16	NULL
.	NULL

5-GTAAC-CATTATAAGCTGC-3	NULL
'	NULL
:	NULL
17	NULL
.	NULL
)	NULL

5-GGCGAATTCCGGTCGTGATATG-ACGAGCA-3	NULL
``	NULL
:	NULL
18	NULL
.	NULL

5-GGCGAATTCGCCTGAAGCTTGATGTGG-TCC-3	NULL
'	NULL
:	NULL
19	NULL
.	NULL

5-GGCGAATTCGCTCCAAGCCTCATTGTAGGCG-3	NULL
'	NULL
:	NULL
20	NULL
.	NULL

5-GGCGAATTCAGGGCGAGAGATGGTGGGG-3	NULL
'	NULL
:	NULL
21	NULL
.	NULL

5-GGC-GAATTCACTACAGATGGTCAAAGGCTG-3	NULL
'	NULL
:	NULL
22	NULL
.	NULL

5-GGCGAAIT-CGCTCCAGGCCTCACTGTAGGAGGA-3	NULL
'	NULL
:	NULL
23	NULL
.	NULL

5-GGCGAATTCA-GGTCGAGAGATGGCGAGCA-3	NULL
'	NULL
:	NULL
24	NULL
.	NULL

5	NULL
-GGCGAATTCGCTGTGGT-CCTGCAGTTTGAC-3	NULL
'	NULL
:	NULL
25	NULL
,	NULL
5-GGCGAATTCGCTCCAAGCTTCAT-TGTAAGTTGT-3	NULL
'	NULL
:	NULL
26	NULL
.	NULL

5-GGCGAATTCTCAAGGCGGTTACTCCA-GCG-3	NULL
'	NULL
:	NULL
27	NULL
.	NULL

5	NULL
-GGCGAATTCAGGTTCATGATGTTGGTGGTA-3*	NULL
:	NULL
28	NULL
.	NULL

5-GGCGAATTCGCTTTGCCATTCGTTATAGTGCCC-3	NULL
'	NULL
;	NULL
29	NULL
,	NULL
5'-GAGATCGATTGGCGGTTACTCCAGCGGTTCGG-3	NULL
``	NULL
;	NULL
30	NULL
.	NULL

5-GAG-GGATCCTAATGGTTGTGACTGGCCTGATTT-3	NULL
'	NULL
:	NULL
31	NULL
.	NULL

GACCAGGAGTCGTTGTACGAGGA-3	NULL
``	NULL
:	NULL
32	NULL
.	NULL

5-GGCTCTAGACCA-ACCCGGGGCTGCTTGGCT-3	NULL
'	NULL
:	NULL
33	NULL
.	NULL

5-GGCGAATTCGGTCATAGG-CAGTGGCGGCT-3*	NULL
:	NULL
34	NULL
.	NULL

5-GCGAAGCTTGGTGCCATCAGTGTTT-GGTGCC-3	NULL
'	NULL
;	NULL
35	NULL
.	NULL

5-GATCTCCGGAGGACAGTCCTCCGATGTCCG-3	NULL
'	NULL
;	NULL
36	NULL
,	NULL
5-GATCCGGACATCGGAGGACTGTCCTCCGGA-3	NULL
.	NULL

Transient	NULL
transfection	NULL
,	NULL
luciferase	NULL
and	NULL
CAT	NULL
assays	NULL
The	NULL
B	NULL
cell	NULL
line	NULL
M12.4.1	NULL
and	NULL
the	NULL
plasma	NULL
cells	NULL
SP2/0	NULL
and	NULL
J558L	NULL
were	NULL
transiently	NULL
transfected	NULL
by	NULL
electroporation	NULL
.	NULL

Typically	NULL
2X	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
DNA	NULL
(	NULL
amounts	NULL
indicated	NULL
in	NULL
figure	NULL
legends	NULL
)	NULL
in	NULL
400	NULL
pl	NULL
PBS	NULL
for	NULL
5	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
a	NULL
cuvette	NULL
with	NULL
an	NULL
interelectrode	NULL
distance	NULL
of	NULL
0.4	NULL
cm	NULL
and	NULL
then	NULL
electroporated	NULL
with	NULL
a	NULL
Bio-Rad	NULL
gene	NULL
pulser	NULL
set	NULL
at	NULL
350	NULL
V	NULL
and	NULL
500	NULL
uF	NULL
.	NULL

After	NULL
incubation	NULL
for	NULL
15-20	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

cells	NULL
were	NULL
transferred	NULL
to	NULL
15	NULL
ml	NULL
of	NULL
culture	NULL
medium	NULL
and	NULL
grown	NULL
for	NULL
40	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

RAC6GS	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
calcium	NULL
phosphate	NULL
co-precipitation	NULL
.	NULL

For	NULL
luciferase	NULL
and	NULL
CAT	NULL
assays	NULL
.	NULL

cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
,	NULL
resuspended	NULL
in	NULL
100	NULL
pul	NULL
of	NULL
0.25	NULL
M	NULL
Tris	NULL
buffer	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
and	NULL
lysed	NULL
by	NULL
three	NULL
freeze-thaw	NULL
cycles	NULL
.	NULL

Thirty	NULL
microliters	NULL
of	NULL
each	NULL
supernatant	NULL
were	NULL
used	NULL
for	NULL
measuring	NULL
the	NULL
luciferase	NULL
activity	NULL
in	NULL
a	NULL
CliniLumat	NULL
bioluminescence	NULL
counter	NULL
(	NULL
Berthold	NULL
,	NULL
Wildbach	NULL
,	NULL
Germany	NULL
)	NULL
and	NULL
for	NULL
determining	NULL
the	NULL
CAT	NULL
protein	NULL
-	NULL
concentration	NULL
|	NULL
by	NULL
ELISA	NULL
(	NULL
CAT-ELISA	NULL
kit	NULL
,	NULL
-	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
.	NULL

respectively	NULL
.	NULL

Where	NULL
indicated	NULL
.	NULL

these	NULL
extracts	NULL
were	NULL
also	NULL
used	NULL
for	NULL
EMSA	NULL
analysis	NULL
(	NULL
4	NULL
pl	NULL
per	NULL
reaction	NULL
)	NULL
.	NULL

RNA	NULL
preparation	NULL
and	NULL
RNase	NULL
protection	NULL
assay	NULL
Cytoplasmic	NULL
RNA	NULL
was	NULL
prepared	NULL
according	NULL
to	NULL
Favaloro	NULL
et	NULL
a/	NULL
.	NULL

(	NULL
1980	NULL
)	NULL
.	NULL

The	NULL
nuclear	NULL
pellets	NULL
which	NULL
were	NULL
obtained	NULL
as	NULL
a	NULL
side	NULL
product	NULL
of	NULL
this	NULL
method	NULL
1981	NULL
P.Dorfler	NULL
and	NULL
M.Busslinger	NULL
were	NULL
used	NULL
for	NULL
preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

RNase	NULL
protection	NULL
assays	NULL
were	NULL
performed	NULL
according	NULL
to	NULL
Vitelli	NULL
er	NULL
al	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
except	NULL
that	NULL
a	NULL
hybridization	NULL
temperature	NULL
of	NULL
60°C	NULL
(	NULL
instead	NULL
of	NULL
65°C	NULL
)	NULL
and	NULL
a	NULL
rabbit	NULL
B-globin	NULL
riboprobe	NULL
(	NULL
Barberis	NULL
et	NULL
al..	NULL
1990	NULL
)	NULL
were	NULL
used	NULL
.	NULL

Nuclear	NULL
extract	NULL
preparation	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
The	NULL
nuclei	NULL
obtained	NULL
as	NULL
pellet	NULL
during	NULL
the	NULL
preparation	NULL
of	NULL
cytoplasmic	NULL
RNA	NULL
from	NULL
transfected	NULL
cells	NULL
(	NULL
see	NULL
above	NULL
)	NULL
were	NULL
extracted	NULL
for	NULL
15	NULL
min	NULL
at	NULL
4°C	NULL
with	NULL
50	NULL
ul	NULL
of	NULL
a	NULL
buffer	NULL
containing	NULL
420	NULL
mM	NULL
NaCl	NULL
,	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
and	NULL
a	NULL
protease	NULL
inhibitor	NULL
cocktail	NULL
previously	NULL
described	NULL
(	NULL
Adams	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Equal	NULL
protein	NULL
amounts	NULL
of	NULL
these	NULL
nuclear	NULL
extracts	NULL
or	NULL
,	NULL
where	NULL
indicated	NULL
,	NULL
of	NULL
whole	NULL
cell	NULL
extracts	NULL
obtained	NULL
by	NULL
freeze-thaw	NULL
lysis	NULL
(	NULL
see	NULL
above	NULL
)	NULL
were	NULL
analysed	NULL
by	NULL
EMSAs	NULL
according	NULL
to	NULL
Barberis	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
except	NULL
for	NULL
the	NULL
further	NULL
addition	NULL
of	NULL
20	NULL
ug	NULL
BSA	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
.	NULL

EMSAs	NULL
with	NULL
GAL4-Pax	NULL
fusion	NULL
proteins	NULL
were	NULL
carried	NULL
out	NULL
by	NULL
including	NULL
6	NULL
mM	NULL
MgCl	NULL
;	NULL
in	NULL
the	NULL
binding	NULL
reaction	NULL
and	NULL
by	NULL
prolonging	NULL
the	NULL
incubation	NULL
time	NULL
to	NULL
20	NULL
min	NULL
.	NULL

End-labelled	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
Pax	NULL
binding	NULL
sites	NULL
of	NULL
the	NULL
H2A-2.2	NULL
and	NULL
CD19	NULL
genes	NULL
(	NULL
Czerny	NULL
et	NULL
al..	NULL
1993	NULL
)	NULL
were	NULL
used	NULL
as	NULL
DNA	NULL
probes	NULL
to	NULL
detect	NULL
BSAP	NULL
proteins	NULL
and	NULL
the	NULL
double-stranded	NULL
oligonucleotide	NULL
35/36	NULL
to	NULL
detect	NULL
GAL4	NULL
fusion	NULL
proteins	NULL
.	NULL

Indirect	NULL
immunofluorescence	NULL
assay	NULL
COP-8	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
4	NULL
ug	NULL
of	NULL
BSAP	NULL
expression	NULL
plasmids	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Adams	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Two	NULL
days	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
directly	NULL
fixed	NULL
on	NULL
the	NULL
plate	NULL
by	NULL
incubation	NULL
with	NULL
3.7	NULL
%	NULL
formaldehyde	NULL
in	NULL
PBS	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
(	NULL
RT	NULL
)	NULL
and	NULL
permeabilized	NULL
with	NULL
0.5	NULL
%	NULL
NP-40	NULL
,	NULL
0.5	NULL
%	NULL
BSA	NULL
in	NULL
PBS	NULL
for	NULL
15	NULL
min	NULL
at	NULL
RT	NULL
.	NULL

Circular	NULL
areas	NULL
of	NULL
~1.5	NULL
cm	NULL
diameter	NULL
were	NULL
marked	NULL
on	NULL
the	NULL
plate	NULL
with	NULL
a	NULL
hydrophobic	NULL
pen	NULL
,	NULL
and	NULL
cells	NULL
within	NULL
this	NULL
area	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
rabbit	NULL
polyclonal	NULL
serum	NULL
directed	NULL
against	NULL
the	NULL
BSAP	NULL
paired	NULL
domain	NULL
(	NULL
Adams	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
followed	NULL
by	NULL
detection	NULL
with	NULL
FITC-conjugated	NULL
goat	NULL
anti-rabbit	NULL
antibodies	NULL
(	NULL
each	NULL
incubations	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
moist	NULL
environment	NULL
)	NULL
.	NULL

Antibody	NULL
dilutions	NULL
and	NULL
washing	NULL
steps	NULL
were	NULL
performed	NULL
with	NULL
0.5	NULL
%	NULL
BSA	NULL
in	NULL
PBS	NULL
.	NULL

The	NULL
stained	NULL
cells	NULL
were	NULL
embedded	NULL
in	NULL
Elvanol	NULL
containing	NULL
0.5	NULL
ug/ml	NULL
of	NULL
DAPI	NULL
and	NULL
photographed	NULL
in	NULL
a	NULL
fluorescence	NULL
microscope	NULL
.	NULL

Acknowledgements	NULL
We	NULL
are	NULL
grateful	NULL
to	NULL
Thomas	NULL
Czerny	NULL
for	NULL
providing	NULL
the	NULL
sea	NULL
urchin	NULL
Pax-258	NULL
cDNA	NULL
,	NULL
to	NULL
Anders	NULL
Fjose	NULL
for	NULL
the	NULL
zebrafish	NULL
Pax-b	NULL
cDNA	NULL
.	NULL

to	NULL
G.Schaffner	NULL
for	NULL
oligonucleotide	NULL
synthesis	NULL
,	NULL
to	NULL
[	NULL
Botto	NULL
and	NULL
R.Kurzbauer	NULL
for	NULL
DNA	NULL
sequencing	NULL
,	NULL
to	NULL
H.Tkadletz	NULL
for	NULL
graphical	NULL
work	NULL
and	NULL
to	NULL
M.Cotten	NULL
and	NULL
T.Jenuwein	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
,	NULL
in	NULL
part	NULL
,	NULL
supported	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Austrian	NULL
Industrial	NULL
Research	NULL
Promotion	NULL
Fund	NULL
.	NULL

References	NULL
Adams.B	NULL
.	NULL

,	NULL
Dérfler	NULL
,	NULL
P.	NULL
,	NULL
Aguzzi	NULL
,	NULL
A.	NULL
,	NULL
Kozmik	NULL
,	NULL
Z.	NULL
,	NULL
Urbdnek.P	NULL
.	NULL

,	NULL
Maurer-Fogy.1	NULL
.	NULL

and	NULL
Busslinger	NULL
,	NULL
.M	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
6	NULL
,	NULL
1589-1607	NULL
.	NULL

Baichwal.V.R	NULL
.	NULL

,	NULL
Park	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Tjian	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Genes	NULL
Dew	NULL
.	NULL

,	NULL
6	NULL
,	NULL
1493-1502	NULL
.	NULL

Barberis	NULL
.	NULL

A.	NULL
,	NULL
Superti-Furga	NULL
,	NULL
G.	NULL
,	NULL
Vitelli.L	NULL
.	NULL

,	NULL
Kemler.J	NULL
.	NULL

and	NULL
Busslinger.M	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
3	NULL
,	NULL
663-675	NULL
.	NULL

Barberis	NULL
.	NULL

A..	NULL
Widenhorn	NULL
,	NULL
K.	NULL
,	NULL
Vitelli	NULL
,	NULL
L	NULL
.	NULL

and	NULL
Busslinger.M	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
4	NULL
,	NULL
849-859	NULL
.	NULL

Bergers	NULL
,	NULL
G.	NULL
,	NULL
Graninger.P	NULL
.	NULL

,	NULL
Braselmann	NULL
.	NULL

$	NULL
.	NULL

,	NULL
Wrighton.C	NULL
.	NULL

and	NULL
Busslinger.M	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
15	NULL
,	NULL
3748-3758	NULL
.	NULL

Bopp	NULL
,	NULL
.D	NULL
.	NULL

,	NULL
Jamet.E..	NULL
Baumgartner.S..	NULL
Burri.M	NULL
.	NULL

and	NULL
NolL.M	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
EMBO	NULL
J..	NULL
8	NULL
,	NULL
3447-3457	NULL
.	NULL

Brown	NULL
,	NULL
H.J	NULL
.	NULL

,	NULL
Sutherland.J.A	NULL
.	NULL

,	NULL
Cook	NULL
,	NULL
A.	NULL
,	NULL
Bannister	NULL
.	NULL

A.J	NULL
.	NULL

and	NULL
Kouzarides.T	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
EMBO	NULL
J..	NULL
14	NULL
.	NULL

124-131	NULL
.	NULL

Busslinger	NULL
,	NULL
.M	NULL
.	NULL

and	NULL
Urbdnek	NULL
,	NULL
P	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

,	NULL
5	NULL
.	NULL

595-601	NULL
.	NULL

Busslinger	NULL
,	NULL
M.	NULL
,	NULL
Klix.N	NULL
.	NULL

,	NULL
Pfeffer	NULL
,	NULL
P..	NULL
Graninger.P.G	NULL
.	NULL

and	NULL
Kozmik.Z	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
in	NULL
press	NULL
.	NULL

Chalepakis	NULL
,	NULL
G.	NULL
,	NULL
Fritsch	NULL
,	NULL
R.	NULL
,	NULL
Fickenscher	NULL
,	NULL
H..	NULL
Deutsch.U..	NULL
Goulding.M	NULL
.	NULL

and	NULL
Gruss	NULL
,	NULL
P	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Cell	NULL
,	NULL
66	NULL
,	NULL
873-884	NULL
.	NULL

Chalepakis	NULL
,	NULL
G.	NULL
,	NULL
Jones	NULL
,	NULL
F.S	NULL
.	NULL

,	NULL
Edelman	NULL
,	NULL
G.M	NULL
.	NULL

and	NULL
Gruss.P	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Nat	NULL
!	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
91	NULL
,	NULL
12745-12749	NULL
.	NULL

Czerny.T	NULL
.	NULL

and	NULL
Busslinger	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol..	NULL
15	NULL
.	NULL

2858-2871	NULL
.	NULL

Czerny.T	NULL
.	NULL

,	NULL
Schaffner	NULL
,	NULL
G	NULL
.	NULL

and	NULL
Busslinger.M	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Genes	NULL
Dev..	NULL
7	NULL
,	NULL
2048-2061	NULL
.	NULL

Dressler.G.R..	NULL
Deutsch	NULL
,	NULL
U..	NULL
Chowdhury.K	NULL
.	NULL

,	NULL
Normnes.H.0	NULL
.	NULL

and	NULL
Gruss.P	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Development	NULL
,	NULL
109	NULL
,	NULL
787-795	NULL
.	NULL

1982	NULL
Dubendorff	NULL
,	NULL
J.W..	NULL
Whittaker.L.J..	NULL
Eltman.J.T	NULL
.	NULL

and	NULL
Lipsick.J.S	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Genes	NULL
Dev..	NULL
6	NULL
,	NULL
2524-2535	NULL
.	NULL

Favaloro.J..	NULL
Treisman.R	NULL
.	NULL

and	NULL
Kamen.R	NULL
.	NULL

(	NULL
1980	NULL
)	NULL
Methods	NULL
Enzymol..	NULL
65	NULL
,	NULL
718-749	NULL
.	NULL

Fickenscher.H.R..	NULL
Chalepakis.G	NULL
.	NULL

and	NULL
Gruss.P	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
DNA	NULL
Cell	NULL
Biol..	NULL
12	NULL
.	NULL

381-391	NULL
.	NULL

Glaser.T..	NULL
Jepeal.L..	NULL
Edwards.J.G..	NULL
Young.S.R..	NULL
Favour.J	NULL
.	NULL

and	NULL
Maas.R.L	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Nature	NULL
Genet..	NULL
7	NULL
.	NULL

463-471	NULL
.	NULL

Glimcher.L.H	NULL
.	NULL

,	NULL
Hamano.T..	NULL
Asofsky.R..	NULL
Heber-Katz.E..	NULL
Schwartz.R.H	NULL
.	NULL

and	NULL
Paul	NULL
.	NULL

W.E	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
Nature	NULL
,	NULL
298	NULL
,	NULL
283-286	NULL
.	NULL

Jayaraman	NULL
,	NULL
P.-S..	NULL
Hirst.K	NULL
.	NULL

and	NULL
Goding.C.R	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
EMBO	NULL
J..	NULL
13	NULL
,	NULL
2192-2199	NULL
.	NULL

Kowenz-Leutz.E	NULL
.	NULL

,	NULL
Twamley.G..	NULL
Ansieau	NULL
.	NULL

$	NULL
.	NULL

and	NULL
Leutz.A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Genes	NULL
Dev..	NULL
8	NULL
.	NULL

2781-2791	NULL
.	NULL

Kozmik.Z..	NULL
Wang.S	NULL
.	NULL

,	NULL
.	NULL

Dorfler.P	NULL
.	NULL

,	NULL
Adams.B	NULL
.	NULL

and	NULL
Busslinger.M	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol..	NULL
12	NULL
,	NULL
2662-2672	NULL
.	NULL

Kozmik.Z	NULL
.	NULL

,	NULL
Kurzbauer.R..	NULL
Dérfler.P	NULL
.	NULL

and	NULL
Busslinger.M	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol..	NULL
13	NULL
.	NULL

6024-6035	NULL
.	NULL

Krauss.S..	NULL
Johansen.T..	NULL
Korzh.V	NULL
.	NULL

and	NULL
Fjose.A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Development	NULL
.	NULL

113	NULL
.	NULL

1193-1206	NULL
.	NULL

Murata.Y..	NULL
Kim.H.G..	NULL
Rogers.K.T	NULL
.	NULL

,	NULL
Udvadia.A.J	NULL
.	NULL

and	NULL
HorowitzJ.M	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem..	NULL
269	NULL
,	NULL
20674-20681	NULL
.	NULL

Nerlov.C	NULL
.	NULL

and	NULL
Ziff.E.B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
8	NULL
.	NULL

350-362	NULL
.	NULL

Neurath.M.F	NULL
.	NULL

,	NULL
Strober.W	NULL
.	NULL

and	NULL
Wakatsuki.Y	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol..	NULL
153	NULL
.	NULL

730-742	NULL
.	NULL

NolL.M	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev..	NULL
3	NULL
,	NULL
595-605	NULL
.	NULL

Plachov.D..	NULL
Chowdhury.K..	NULL
Walther.C..	NULL
Simon.D..	NULL
Guenet.J.L	NULL
.	NULL

and	NULL
Gruss	NULL
,	NULL
P	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Development	NULL
,	NULL
110	NULL
,	NULL
643-651	NULL
.	NULL

Pratt	NULL
.	NULL

M.A.C..	NULL
KralovaJ	NULL
.	NULL

and	NULL
McBurney.M.W	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol..	NULL
10	NULL
,	NULL
6445-6453	NULL
.	NULL

Rosenfeld.C..	NULL
Goutner.A..	NULL
Choquet.C	NULL
.	NULL

,	NULL
Venuat	NULL
.	NULL

A.M..	NULL
Kayibanda.B..	NULL
Pico.J.L	NULL
.	NULL

and	NULL
Greaves	NULL
.	NULL

M.F	NULL
.	NULL

(	NULL
1977	NULL
)	NULL
Nature	NULL
,	NULL
267	NULL
.	NULL

841-843	NULL
.	NULL

Rothman.P..	NULL
Li.S.C..	NULL
Gorham.B..	NULL
Glimcher.L..	NULL
AIt.F	NULL
.	NULL

and	NULL
Boothby.M	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol..	NULL
11	NULL
.	NULL

5551-5561	NULL
.	NULL

Sanyanusin.P..	NULL
Schimmenti.L.A..	NULL
McNoe.L.A..	NULL
Ward.T.A..	NULL
Pierpont	NULL
.	NULL

M.E.M..	NULL
Sullivan	NULL
.	NULL

M.J..	NULL
Dobyns	NULL
.	NULL

and	NULL
Eccles.M.R	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Nature	NULL
Genet	NULL
.	NULL

,	NULL
9	NULL
.	NULL

358-364	NULL
.	NULL

Schiifer.B.W	NULL
.	NULL

,	NULL
Czerny.T	NULL
.	NULL

,	NULL
Bernasconi	NULL
,	NULL
M..	NULL
Genini.M	NULL
.	NULL

and	NULL
Busslinger.M	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res..	NULL
22	NULL
,	NULL
4574-4582	NULL
.	NULL

K..	NULL
Georgiev.O	NULL
.	NULL

and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1992	NULL
)	NULL
EMBO	NULL
J..	NULL
11	NULL
.	NULL

4961-4968	NULL
.	NULL

Shi.Y..	NULL
Kroeger.PE	NULL
.	NULL

and	NULL
Morimoto.R.1	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol..	NULL
15	NULL
,	NULL
4309-4318	NULL
.	NULL

Singh.M	NULL
.	NULL

and	NULL
Birshtein.B.K	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
13	NULL
,	NULL
3611-3622	NULL
.	NULL

Song.D.-L.	NULL
,	NULL
Chalepakis.G	NULL
.	NULL

,	NULL
Gruss.P	NULL
.	NULL

and	NULL
Joyner	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Development	NULL
,	NULL
122	NULL
,	NULL
627-635	NULL
.	NULL

Stuart.E.T..	NULL
Kioussi.C..	NULL
and	NULL
Gruss.P	NULL
,	NULL
(	NULL
1994	NULL
)	NULL
Ammu	NULL
.	NULL

Rev	NULL
.	NULL

Genet	NULL
.	NULL

,	NULL
28	NULL
.	NULL

219-236.	NULL
,	NULL
Treisman.J..	NULL
Harris.E	NULL
.	NULL

and	NULL
Desplan	NULL
,	NULL
C	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Genes	NULL
Dev..	NULL
5	NULL
,	NULL
594-604	NULL
.	NULL

Tyndall.C..	NULL
La.M.G	NULL
.	NULL

,	NULL
Thacker	NULL
,	NULL
C.M	NULL
.	NULL

,	NULL
FavaloroJ	NULL
.	NULL

and	NULL
Kamen.R	NULL
.	NULL

(	NULL
1981	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
9	NULL
,	NULL
6231-6250	NULL
.	NULL

Urbdnek.P	NULL
.	NULL

,	NULL
Wang.Z.-Q..	NULL
Fetka.L..	NULL
Wagner.E.F	NULL
.	NULL

and	NULL
Busslinger.M	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Cell	NULL
,	NULL
79	NULL
,	NULL
901-912	NULL
.	NULL

Vitelli	NULL
,	NULL
L..	NULL
Lauber.B	NULL
.	NULL

,	NULL
Birnstiel.M.L	NULL
.	NULL

and	NULL
Busslinger.M	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Dev	NULL
.	NULL

Biol..	NULL
127	NULL
,	NULL
54-63	NULL
.	NULL

Walther.C..	NULL
Guenet.J.L..	NULL
Simon.D	NULL
.	NULL

,	NULL
Deutsch.U..	NULL
Jostes.B..	NULL
Goulding	NULL
,	NULL
M.D	NULL
.	NULL

,	NULL
Plachov.D..	NULL
Balling.R	NULL
.	NULL

and	NULL
Gruss.P	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Genomics	NULL
.	NULL

11	NULL
.	NULL

424-434	NULL
,	NULL
Westin.G..	NULL
Gerster.T..	NULL
Miller	NULL
.	NULL

Schaffner.G	NULL
.	NULL

and	NULL
Schaffner.W	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res..	NULL
15	NULL
,	NULL
6787-6798	NULL
.	NULL

Zannini	NULL
.	NULL

M..	NULL
Francis-Lang.H..	NULL
Plachov.D	NULL
.	NULL

and	NULL
Di	NULL
Lauro.R	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
12	NULL
,	NULL
4230-4241	NULL
.	NULL

Zuo.J	NULL
.	NULL

,	NULL
Rungger.D	NULL
.	NULL

and	NULL
Voellmy.R	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
15	NULL
,	NULL
4319-4330	NULL
.	NULL

Received	NULL
on	NULL
October	NULL
25	NULL
,	NULL
1995	NULL
;	NULL
revised	NULL
on	NULL
December	NULL
1	NULL
.	NULL

1995	NULL

